International Pharmacy.pdf - Free Web Hosting Area

1

Bachelor of Pharmacy Program

(International Program)

New Program 2004

---------------------

1. Title of Curriculum

Bachelor of Pharmacy Program (International)

2. Title of Degree

Full Name : Bachelor of Pharmacy

Abbreviation Name : B. Pharm.

3. Responsible Organization

Faculty of Pharmacy, Silpakorn University

4. Philosophy and Objectives

Academic policy for pharmacy education is to produce graduates with well-round

scholastic activities, good morality and professional etiquette, and experiences in various

professional disciplines to efficiently serve the public and community. Originally,

Pharmaceutical discipline involves arts and sciences of seeking and manufacturing drugs or

drug dosage forms from both natural and synthetic materials. It also covers the knowledges of

drug distribution, prescription, drug used evaluation, as well as drug information provided to

patients and health care personnel. Trends and directions of Pharmaceutical discipline at

present and in the future involve more and more in the aspect of integrated, multidisciplinary

and interdisciplinary mode of operation. Pharmacy and Pharmaceutical Sciences would now

concern many other disciplinary areas that can be brought into relation such as Health Related

Economic Problems, Sciences & Technology, Social & Behavioural Sciences, Archaeology &

Anthropology, Environments and Management, and Natural Conservation & Restoration. In

addition, The contextual changes of Higher Education Reforms in Thailand as well as the

rapid growth and advancement in sciences and technology including industrial activities and

professional practices at global standardization will definitely challenge Thai Universities to

elaborate higher international – class quality. Faculty of Pharmacy, Silpakorn University

realizes the needs to develop and offer international management of Pharmaceutical

Education of global standard which will of course lead to marketable competitions at the eage

of global free trade and services.

2

The general objectives of this Program are:

1.1 To develop and heighten quality of higher education in Pharmacy to meet

international standards.

1.2 To produce qualified graduates who can professionally apply both knowledge and

practical skill in pharmacy to efficiently serve the market needs both outside and

inside Thailand.

1.3 To produce qualified graduates who can efficiently continue their graduate

program abroad.

5. Program Commencement

June 2005

6. Eligibility for Application

An applicant must possess :

6.1 A certificate of high school level or the equivalent.

6.2 Proficiency in English by passing the required score in English examination

prescribed by Faculty Board of Admission or possess minimum TOEFL score of

500 or IELTS score of 5.5 with the exemption of those who graduate from

international program. The TOEFL score report or IELTS score report used for

application must not exceed 2 year.

6.3 Clear record of good conduct.

Students in the program is eligible to transfer to a 6-year Doctor of Pharmacy

Program which will be offered in 3 areas of concentration. Additionally, they are

allowed to transfer to a special project of undergraduate program with the approval

of the Faculty Committee.

7. Admission Criteria

Undergraduate students for international program are admitted through a selection

examination and interview administered annually by the Faculty of Pharmacy, Silpakorn

University.

8. Academic System

8.1 The academic system is based on the semester-credit system. Each academic

year is divided into two semesters. Each semester consists of a mininum of fifteen weeks. In

addition, 8 week courses may be offered during summer recess depending on availability of

resources.

3

8.2 Credit points units are counted and calculated as follow:

8.2.1 Lecture courses : 1 credit is equivalent to one hour per week

8.2.2 Practical courses : 1 credit is equivalent to 2-3 hours per week

8.2.3 Internship or Professional practice : 1 credits is equivalent to a minimum

of 45 hours per semester

8.2.4 Senior project : 1 credit is equivalent to a minimum of 45 hours per

semester

8.2.5 The amount of credits is calculated by using the assumption of the

course duration : lecture courses(l), practical courses(p) and self study

(s) divided by three.

The amount of credits = l+p+s

3

8.3 The language media for instruction in this program is English.

9. Study Duration

Students may complete the program within five years, but not exceeding ten years.

10. Enrollment

Full-time students must enroll for at least 12 credits but not exceeding 22 credits in each

semester. Enrolling for the summer session must not exceed 9 credits.

11. Grading System

11.1 Grading system for course work is A,B+,B,C+,C,D+,D,F and S/U. The overall

scholastic performance of a student is averaged and expressed in a semester as

a Grade-Point Average (GPA) and annually as a Cumulative Grade-Point

Average (cum.GPA)

11.2 Criteria for Graduation

To graduate, a student must:

11.2.1 pass all the required courses and receive total credits as stated in the

curriculum within ten years.

11.2.2 maintain cumulative GPA of at least 2.00 for the whole curriculum.

11.2.3 maintain cumulative GPA of at least 2.00 for pharmacy courses for the

bachelor degree level.

11.2.4 pass the professional practice courses of at least 500 practicing hours

with satisfaction and pass the senior project of not less than 45 working

hours.

4

12. Faculty Staff

Staff at the Faculty of Pharmacy will be responsible for teaching and managing the

program, give academic advice to students, and supervise for the senior project. The names of

the staff are listed in Appendix A.

13. Projected Enrollment

Student Status/year 2005 2006 2007 2008 2009

New students 60 60 60 60 60

2nd year students - 60 60 60 60

3rd year students - - 60 60 60

4th year students - - - 60 60

5th year students - - - - 60

Total 60 120 180 240 300

Estimated graduates - - - - 60

14. Facilities

14.1 Administration office and classrooms are located mainly in the building of the

Faculty of Pharmacy, Silpakorn University.

14.2 Other classrooms are located in many faculties in Silpakorn University which offer

courses listed in this curriculum.

14.3 Hospitals, Health Service Institutes, Manufacturing and other related organizations

of both public and private sections, both inside and outside Thailand, are

available for professional practice.

14.4 Computer labs at Faculty of Pharmacy and University Computer center are open

to student access.

14.5 The Faculty of Pharmacy - owned databases as well as Web CT courses

management and tutorial system are open for student access.

15. Library

Books, magazines, computers, and other resources related to the program are

accessible from the Faculty of Pharmacy's Reference Room "Prachote Plengvidhya" and

University's Central Library at Sanamchandra Palace Campus.

Items Quantities

15.1 Books : Thai language 2,165 titles

Foreign language 2,870 titles

15.2 Journals :Thai language 30 titles

Foreign language 60 titles

5

Databases such as Science Direct, Applied Science & Technology, Full text

General Science Abstracts, CAB Abstract, Medline, Dissertation Abstract Online and other

pharmacy and related databases of at least 1,482 Gigabytes are also available. In addition,

the Faculty of Pharmacy, Silpakorn University will improve the databases to 10 Terabytes

within 2007.

16. Budget

The estimated cost per each student of the program is 102,765 Baht / year.

17. Curriculum

17.1 A minimum of 188 accumulate credits are required.

17.2 Curriculum Structure

17.2.1 General Education Courses (minimum) 30 credits.

17.2.2 Specialization Courses (minimum) 152 credits.

Fundamental Courses in Sciences 30 credits.

Pharmacy Core Courses (minimum) 122 credits.

17.2.3 Free Electives (minimum) 6 credits.

17.3 Course Details

1. General Education Courses (minimum) 30 credits.

1.1 Compulsory Courses 20 credits.

Students have to enroll the following courses or other equivalent courses

as approved by the Faculty Committee.

- Languages 9 credits.

080 176 Language and Communication 3(3-0-6)

550 155 English for Pharmacy Students I 3(2-2-5)

550 158 English for Pharmacy Students II 3(2-2-5)

- Humanities 4 credits.

080 122 Professional Ethics 2(2-0-4)

550 153 Introductory Pharmaceutical Design 2(1-3-2)

- Social Sciences 2 credits.

080 144 Principles of Research 2(2-0-4)

- Mathematics and Basic Sciences 5 credits.

511 103 Mathematics for Biological Sciences Students 3(3-0-6)

563 251 Basic Public Health 2(2-0-4)

6

1.2 Compulsory Electives : students must choose one any foreign language

offered by the University of not less than 6 credits and must be two consecutive courses

of 6 credits.

080 179 Basic French I 3(2-2-5)

080 180 Basic French II 3(2-2-5)

080 183 Basic German I 3(2-2-5)

080 184 Basic German II 3(2-2-5)

080 187 Basic Chinese I 3(2-2-5)

080 188 Basic Chinese II 3(2-2-5)

080 189 Basic Japanese I 3(2-2-5)

080 190 Basic Japanese II 3(2-2-5)

1.3 Electives (minimum) 4 credits

Student chooses 4 credits from the following courses or other equivalent

courses as approved by the Faculty Committee:

080 101 Man and Creativity 3(3-0-6)

080 107 Music Appreciation 2(2-0-4)

080 114 Art Appreciation 2(2-0-4)

080 117 Literary Appreciation 2(2-0-4)

080 119 Eastern Civilization 2(2-0-4)

080 126 Man and His Environment 3(3-0-6)

080 127 Introduction to Psychology 2(2-0-4)

080 133 Economics in Everyday Life 2(2-0-4)

080 135 Law and Society 2(2-0-4)

415 151 Southeast Asian World 2(2-0-4)

449 106 Conservation of Resources and Environment 2(2-0-4)

550 101 Basic Computer Applications in Pharmaceutical Sciences 2(1-3-2)

550 156 Introduction to Pharmaceutical Dosage Forms and

Technology 2(2-0-4)

* 554 101 Herbal Medicine 3(3-0-6)

* 554 102 Drug Education 3(3-0-6)

* 554 103 Man and Toxic Substances 3(3-0-6)

* 554 104 Food for Health 3(3-0-6)

565 151 Drug Knowledges 3(3-0-6)

566 101 Pharmaceutical Botany 2(1-3-2)

7

Remarks * Courses offered for non-pharmacy students. Pharmacy students may enroll

these courses under special condition and with consent of the Faculty.

2. Specialization Courses (minimum) 152 credits

2.1 Basic Fundamental in Sciences 30 credits

Students have to enroll the following courses or other equivalent courses as

approved by the Faculty Committee:

2.1.1 Mathematics and Statistics 3 credits

515 203 Statistics for Pharmacy Students 3(2-2-5)

2.1.2 Basic Sciences 27 credits

512 101 General Biology I 3(3-0-6)

512 102 General Biology II 3(3-0-6)

512 103 General Biology Laboratory I 1(0-3-0)

512 104 General Biology Laboratory II 1(0-3-0)

513 101 General Chemistry I 3(3-0-6)

513 102 General Chemistry II 3(3-0-6)

513 220 Physical Chemistry 3(3-0-6)

513 250 Organic Chemistry 3(3-0-6)

514 101 General Physics I 3(3-0-6)

514 102 General Physics II 3(3-0-6)

514 105 General Physics Laboratory for Pharmacy Students 1(0-3-0)

2.2 Pharmacy Core Courses (minimum) 122 credits

2.2.1 Health Sciences 29 credits

561 101 Biopharmacy I 2(2-0-4)

561 102 Biopharmacy II 2(2-0-4)

561 103 Basic Molecular Biology for Pharmacists 1(1-0-2)

561 131 Biopharmacy Laboratory I 1(0-3-0)

561 201 Biopharmacy III 3(3-0-6)

561 202 Biopharmacy IV 2(2-0-4)

561 203 Biopharmacy V 4(4-0-8)

561 231 Biopharmacy Laboratory III 1(0-3-0)

561 232 Biopharmacy Laboratory IV 1(0-3-0)

561 233 Biopharmacy Laboratory V 1(0-3-0)

565 241 Pharmacology I 3(3-0-6)

565 242 Pharmacology II 4(4-0-8)

8

565 243 Toxicology 2(2-0-4)

565 261 Pharmacology Laboratory I 1(0-3-0)

565 263 Toxicology Laboratory 1(0-3-0)

2.2.2 Professional Courses (minimum) 93 credits

- Professional Compulsory Courses 82 credits

550 102 Basic Pharmaceutical Laboratory 1(0-3-0)

550 151 Pharmacy Orientation 1(1-0-2)

550 251 Professional Practice I 1(0-3-0)

550 332 Pharmacy Law 1(1-0-2)

550 351 Professional Practice II 3(0-9-0)

550 352 Professional Practice III 5(0-15-0)

550 359 Computer in Pharmacy 3(2-3-4)

550 361 Seminar in Pharmaceutical Sciences 1(0-3-0)

550 366 Pharmacotherapeutics II 4(3-3-6)

550 367 Pharmacotherapeutics III 4(3-3-6)

550 399 Senior Project 1(0-3-0)

561 211 Biological Products 2(2-0-4)

562 321 Biopharmaceutics and Pharmacokinetics 3(3-0-6)

562 361 Pharmacy Practice 4(3-3-6)

563 254 Basic Pharmacy Administrations I 2(2-0-4)

563 255 Basic Pharmacy Administrations II 2(1-3-2)

564 111 Pharmaceutical Chemistry I 1(1-0-2)

564 121 Pharmaceutical Chemistry Laboratory I 1(0-3-0)

564 131 Pharmaceutical Quality Control I 3(3-0-6)

564 132 Pharmaceutical Quality Control Laboratory I 2(0-6-0)

564 211 Pharmaceutical Chemistry II 3(3-0-6)

564 212 Pharmaceutical Chemistry III 4(4-0-8)

564 231 Pharmaceutical Quality Control II 3(3-0-6)

564 233 Pharmaceutical Quality Control Laboratory II 1(0-3-0)

565 352 Pharmacotherapeutics I 3(3-0-6)

566 111 Pharmacognosy I 3(3-0-6)

566 121 Pharmacognosy Laboratory I 1(0-3-0)

566 211 Pharmacognosy II 2(2-0-4)

566 221 Pharmacognosy Laboratory II 1(0-3-0)

9

567 221 Pharmaceutical Technology I 2(2-0-4)

567 222 Pharmaceutical Technology II 3(3-0-6)

567 223 Pharmaceutical Technology III 3(3-0-6)

567 224 Pharmaceutical Technology IV 2(2-0-4)

567 225 Pharmaceutical Technology V 2(2-0-4)

567 261 Pharmaceutical Technology Laboratory I 1(0-3-0)

567 262 Pharmaceutical Technology Laboratory II 1(0-3-0)

567 263 Pharmaceutical Technology Laboratory III 1(0-3-0)

567 264 Pharmaceutical Technology Laboratory IV 1(0-3-0)

- Professional Elective Courses (minimum) 11 credits

Professional elective courses are categorized into 3 areas of concentration. Students

must choose 11 credits from one of any areas of concentration. Student who wants to enroll

for courses outside the chosen area of concentration should ask for permission from the

Faculty.

: Professional Elective Courses in Pharmaceutical Care

550 202 Nutrition and Nutritional Therapy 2(2-0-4)

550 207 Nutrition and Drug Interactions 2(2-0-4)

550 208 Nutritional Assessment 2(1-3-2)

550 209 Minerals and Vitamins in Nutrition 2(1-3-2)

550 211 Medical Equipment and Accessories 2(1-3-2)

550 212 Intravenous Admixture 2(1-3-2)

550 213 Radiopharmaceuticals 2(2-0-4)

550 214 Hospital Pharmacy 4(3-3-6)

550 215 Pharmacoepidemiology 3(2-3-4)

550 216 Pharmacoeconomics 2(2-0-4)

550 217 Environmental Clinical Toxicology 3(1-6-2)

550 221 Applied Pharmacognosy 2(2-0-4)

550 311 Drug Information in Pharmaceutical Care 3(2-3-4)

550 312 Current Topics in Pharmacy Practice 4(3-3-6)

550 315 Advanced Biopharmaceutics 3(2-3-4)

550 316 Clinical Pharmacokinetics 2(1-3-2)

550 317 Evidence Base in Pharmaceutical Care 3(2-3-4)

550 318 Outcomes Drug Assessment 3(2-3-4)

10

550 319 Drug Assessment 2(1-3-2)

550 320 Drug Use Evaluation I 3(2-3-4)

550 321 Drug Use Evaluation II 3(2-3-4)

550 324 Evaluation of Drug Action 2(2-0-4)

550 330 Clinical Pharmacology 3(2-3-4)

550 333 Evidence Base Phytotherapy 2(2-0-4)

550 334 Current Therapy in Pharmaceutical Care 4(3-3-6)

550 365 Advanced Clinical Pharmacy 4(3-3-6)

550 369 Special Problems in Pharmaceutical Care 2(1-3-2)

: Professional Elective Courses in Pharmaceutical Sciences

550 201 Safety of Foods and Drinking Water 3(1-6-2)

550 203 Pharmaceutical Quality Control IV 2(2-0-4)

550 204 Pharmaceutical Quality Control Laboratory IV 1(0-3-0)

550 205 Drug Biotransformation I 3(3-0-6)

550 206 Drug Biotransformation II 3(3-0-6)

550 210 Immunopathology 3(3-0-6)

550 218 Veterinary Pharmaceutical Products 3(2-3-4)

550 219 Environmental Toxicology 4(3-3-6)

550 220 New Drugs and Current Drugs 2(2-0-4)

550 222 Molecular Biotechnology for Pharmacists 3(3-0-6)

550 223 Pharmaceutical Quality Control III 4(2-6-4)

550 224 Pharmaceutical Quality Control of Food and Cosmetics 4(3-3-6)

550 225 Biomedical Analysis 4(3-3-6)

550 226 Pharmaceutical Chemistry Analysis of Dietotherapeutics 3(2-3-4)

550 227 Mutation Evaluation of Drugs and Environmental Toxic

Substances 3(1-6-2)

550 228 Basic Cellular and Molecular Pharmacology 3(3-0-6)

550 229 Experimental Pharmacology 2(0-6-0)

550 230 Separation Technique in Pharmaceutical Sciences 3(2-3-4)

550 231 Indigenous Medicines 4(3-3-6)

550 232 Agropharmaceutical Sciences 4(3-3-6)

550 233 Biotechnology of Medicinal Plants 3(2-3-4)

550 234 Novel Drug Delivery System 2(2-0-4)

550 235 Cosmeticology 4(2-6-4)

11

550 236 Manufacturing Management 4(3-3-6)

550 237 Quality Control and Quality Assurance Systems 4(3-3-6)

550 238 Tablet Coating 3(2-3-4)

550 239 Introductory Polymer Sciences in Pharmacy 2(2-0-4)

550 240 Industrial Hygiene 4(3-3-6)

550 301 Special Problems in Pharmaceutical Sciences 3(2-3-4)

550 306 Current Topics in Pharmaceutical Sciences 2(2-0-4)

550 307 Advanced Biopharmacy 3(3-0-6)

550 322 Pharmaceutical Synthesis 3(2-3-4)

550 325 Pharmacology of Neuropsychoactive Drugs 4(3-3-6)

550 326 Pharmacology of Cardiovascular Drugs 3(2-3-4)

550 327 Pharmacology of Gastrointestinal Drugs 3(2-3-4)

550 331 Pharmaceutical Packagings 2(2-0-4)

550 338 Principle of Medicinal Chemistry 3(3-0-6)

550 340 Drug Designs 4(3-3-6)

550 343 Advanced Pharmacology and Toxicology 3(3-0-6)

550 347 Research and Development in Medicinal Plants 3(2-3-4)

550 349 Pharmaceutical Formulation and Development 4(2-6-4)

550 355 Pharmaceutical Biotechnology 3(2-3-4)

550 356 Pharmacogenomics 2(2-0-4)

550 360 Computerized Applications in Pharmaceutical Sciences 3(1-6-2)

550 370 Research and Development of Pharmaceutical Products 2(2-0-4)

550 371 Management in Pharmaceutical Sciences 2(2-0-4)

550 372 Quality Assurance in Pharmaceutical Sciences 3(3-0-6)

: Professional Elective Courses in Pharmaceutical Informatics



550 241 Community Pharmacy 3(2-3-4)

550 242 Public Health Pharmacy 3(2-3-4)

550 243 Pharmacists and Rural Health Care 4(2-6-4)

550 244 Drug Marketing and Detailing 3(2-3-4)


550 362 Drug Information Services 3(2-3-4)

550 363 Consumer Protection in Foods and Drugs 3(2-3-4)

550 364 Special Problems in Community Pharmacy 3(2-3-4)

12

550 368 Public Health Administration 3(2-3-4)

550 373 Communication and Health 3(1-6-2)

550 374 Strategy in Pharmacy Administration 3(2-3-4)

550 375 Pharmaceutical Information Management 3(2-3-4)

3. Free Electives (minimum) 6 credits.

Students may choose from courses offered by the University or Faculty, both in

side and outside Thailand. If student chooses courses from professional elective courses as

free electives, grades earned from these courses will be calculated for cum. GPA of pharmacy

courses according to the graduation criteria.

Students may replace the courses in this curriculum with another courses offered

within the University, or those offered by other University subject to approval by the Faculty

Committee.

17.4 Status of the undergraduate students.

Status of an undergraduate student will be classified into 5 categories according to his

or her credit earned from this curriculum ;

- Undergraduate student possessing credit earned less than 32 is equivalent to a

first – year - student.

- Undergraduate student possessing credit earned from 32 to 63 is equivalent to

a second – year – student.

- Undergraduate student possessing credit earned from 64 to 95 is equivalent to

a third – year – student.

- Undergraduate student possessing credit earned from 96 to 127 is equivalent

to a forth – year – student or senior standing.

- Undergraduate student possessing credit earned more than 127 is equivalent

to a fifth – year – student or senior standing.

13

17.5 Study plan

Year 1, First Semester

Course Number Course Title Credits

�� Language and Communication �(�-�-�)

�� … Foreign Language I �(�-�-�)

�� Mathematics for Biological Sciences Students �(�-�-�)

�� General Biology I �(�-�-�)

�� General Biology Laboratory I �(�-�-�)

�� General Chemistry I �(�-�-�)

��( �� General Physics I �(�-�-�)

�� Pharmacy Orientation �(�-�-�)

Total ��

Year 1, Second Semester


�� … Foreign Language II �(�-�-�)

�� General Biology II �(�-�-�)

�� ( General Biology Laboratory II �(�-�-�)

�� General Chemistry II �(�-�-�)

��( �� General Physics II �(�-�-�)

��( �� General Physics Laboratory for Pharmacy

Students

�(�-�-�)

�� Statistics for Pharmacy Students �(�-�-�)

�� Basic Pharmaceutical Laboratory �(�-�-�)

�� Basic Public Health �(�-�-()

Total ��

14



�� Physical Chemistry �(�-�-�)

�� Organic Chemistry �(�-�-�)

�� Introductory Pharmaceutical Design �(�-�-�)

�� English for Pharmacy Students I �(�-�-�)

�� Biopharmacy I �(�-�-()

�� Biopharmacy Laboratory I �(�-�-�)

��( �� Pharmaceutical Chemistry I �(�-�-�)

��( �� Pharmaceutical Chemistry Laboratory I �(�-�-�)

… … Electives in General Education Courses �

Total ��



�� English for Pharmacy Students II �(�-�-�)

�� Biopharmacy II �(�-�-()

�� Biopharmacy III �(�-�-�)

�� Biopharmacy Laboratory III �(�-�-�)

�� ( Basic Pharmacy Administration I �(�-�-()

��( �� Pharmaceutical Quality Control I �(�-�-�)

��( �� Pharmaceutical Quality Control Laboratory I �(�-�-�)

�� Pharmaceutical Technology I �(�-�-()

�� Pharmaceutical Technology Laboratory I �(�-�-�)

… … Electives in General Education Courses �

Total ��

15



�� Biopharmacy IV �(�-�-()

�� Basic Molecular Biology for Pharmacists �(�-�-�)

�� Biopharmacy Laboratory IV �(�-�-�)

��( �� Pharmaceutical Quality Control II �(�-�-�)

��( �� Pharmaceutical Quality Control Laboratory II �(�-�-�)

�� (� Pharmacology I �(�-�-�)

�� Pharmacology Laboratory I �(�-�-�)

�� Pharmacognosy I �(�-�-�)

�� Pharmacognosy Laboratory I �(�-�-�)

�� Pharmaceutical Technology II �(�-�-�)

�� Pharmaceutical Technology Laboratory II �(�-�-�)

Total ��



�� Biopharmacy V (((-�-�)

�� Biopharmacy Laboratory V �(�-�-�)

�� Biopharmaceutics and Pharmacokinetics �(�-�-�)

�� (� Pharmacology II (((-�-�)

�� Pharmacognosy II �(�-�-()

�� Pharmacognosy Laboratory II �(�-�-�)

�� Pharmaceutical Technology III �(�-�-�)

�� Pharmaceutical Technology Laboratory III �(�-�-�)

Total �4

16



�� Professional Ethics �(�-�-()

�� (( Principles of Research �(�-�-()

�� Professional Practice I �(�-�-�)

�� Pharmacy Law �(�-�-�)

�� Biological Products �(�-�-()

�� Pharmacy Practice ((�-�-�)

��( �� Pharmaceutical Chemistry II �(�-�-�)

�� Pharmacotherapeutics I �(�-�-�)

�� ( Pharmaceutical Technology IV �(�-�-()

�� ( Pharmaceutical Technology Laboratory IV �(�-�-�)

Total ��



�� 4 Computer in Pharmacy �(�-�-()

�� Pharmacotherapeutics II ((�-�-�)

�� Basic Pharmacy Administrations II �(�-�-�)

��( �� Pharmaceutical Chemistry III (((-�-�)

�� (� Toxicology �(�-�-()

�� Toxicology Laboratory �(�-�-�)

�� Pharmaceutical Technology V �(�-�-()

Professional Electives (

Total ��

17



�� Professional Practice II �(�-4-�)

�� Seminar in Pharmaceutical Sciences �(�-�-�)

�� Pharmacotherapeutics III ((�-�-�)

�� 44 Senior Project �(�-�-�)

Professional Electives �

Free Electives �

Total ��



�� Professional Practice III �(�-��-�)

Total �

18

17.6 COURSE DESCRIPTION

17.6.1 General Education Courses

080 122 Professional Ethics 2(2-0-4)

Codes and oaths of professional ethics of various disciplines; laws, rules,

regulations and ethical criteria concerning practice and control, with emphasis

on privileges and responsibilities to professions and socials.

080 144 Principles of Research 2(2-0-4)

Conceptual aspects, definition and principles of research ; categorization,

differentiation and processes of performing research ; data collecting, valuating

and reporting of results.

080 176 Language and Communication 3(3-0-6)

A study of basic concept and principles of language communication: a

logical conception and rules of Thai language usage. Practice of the using of

words, idioms, and clauses, the writing of narration, description, explanation,

and discussion.

511 103 Mathematics for Biological Science Students 3(3-0-6)

Graphs of quadratic equations in two variables. Differentiation and

integration. Taylor and Macclaurin series. First – order differential equations.

System of simultaneous linear equations and their solution.

550 101 Basic Computer Applications in Pharmaceutical Sciences 2(1-3-2)

Basic principles of computer especially utilization of software in

pharmaceutical fields; including concepts of data presentation, reporting,

programming for application in pharmacy.

550 153 Introductory Pharmaceutical Design 2(1-3-2)

Appropriate design of pharmaceutical and medicinal packaging in

accordance with professional description and usages.

19

550 155 English for Pharmacy Students I 3(2-2-5)

Practicing skill in reading and speaking with emphasis on data or articles

in health sciences .

550 156 Introduction to Pharmaceutical Dosage Forms and Technology 2(2-0-4)

All pharmaceutical dosage forms including their definitions, classifications,

terminology, compositions, application in pharmacy and basic techniques of

preparation.

550 158 English for Pharmacy Students II 3(2-2-5)

Practicing skill in reading, writing, briefing and concluding, and

presenting, with emphasis on literatures, journal, text books, data or articles in

health sciences.

554 101 Herbal Medicines 3(3-0-6)

Plants and natural products concerning living and surviving of human life

with emphasis on medicinal, food survival and poisonous plants.

554 102 Drug Education 3(3-0-6)

General knowledges about drugs with emphasis on general properties,

sources, concepts, drug action, distribution, dosages, potency, toxicity,

categorization, rational uses, safety measure, household remedies, over – the –

counter drugs, drug abuses, laws and regulations, behavioural drug use

patterns in Thai society.

554 103 Man and Toxic Substances 3(3-0-6)

Fundamental knowledge of toxicity from chemicals, food and others

encountered in everyday life, first-aid treatments, relevant laws, prevention and

selection of the consuming products in order to safeguard consumers from

being intoxicated.

20

554 104 Food for Health 3(3-0-6)

Introduction to bodily need of food, compositions of food, food hygiene

and health, imbalance diets and diseases, eating patterns and health: with

special emphasis on prevention and treatment of the community nutritional

problems.

563 251 Basic Public Health 2(2-0-4)

Basic knowledges in medical demography, epidemiology, biostatistics,

family plannings, population problems, nutrition, mental health and hygiene,

ecological environments, and national health system.

565 151 Drug Knowledges 3(3-0-6)

Pharmacological concepts and origins of drugs and drugs actions,

classification and categorization, principles and conceptual aspects of drug

preparations from resources ; dosages, indications and rational uses: principles

and concepts of drug actions, potency, toxicity and safety measures, drugs

abuses, mechanisms of action, therapeutic values and indications of household

remedies.

566 101 Pharmaceutical Botany 2(1-3-2)

Classification and identification of medicinal plants of economic,

therapeutic and ecological potentials using chemical and biochemical properties,

emphasizing on medicinal plants of Thailand and neighboring countries.

17.6.2 Specialization Courses

17.6.2.1 Basic Fundamental in Sciences

515 203 Statistics for Pharmacy Students 3(2-2-5)

Basic knowledge of statistics and probability. Sampling techniques.

Estimation. Hypothesis testing. Simple regression and correlation. Testing of

nonparametric statistics. One-way and two-way analysis of variance. Basic

concepts of experimental designs.

21

512 101 General Biology I 3(3-0-6)

Prerequisite :

* 512 103 General Biology Laboratory I

* May be taken concurrently

Concepts on biology. Molecular basis of life. Cellular level of organization,

tissues and Organs. Genetics, gene manipulation and evolution. Animal

reproduction and development. Immune system. Human and ecosystem.

Adaptation and animal behavior. Plant technology. Microorganisms and

applications.

512 102 General Biology II 3(3-0-6)

Prerequisite :

* 512 104 General Biology Laboratory II

* may be taken concurrently

Biodiversity. Plant tissues and organs. Cellular respiration and

Photosynthesis in plant. Structures and functions of various systems and

organs of animals including regulatory mechanisms.

512 103 General Biology Laboratory I 1(0-3-0)

Prerequisite :

* 512 101 General Biology I


Laboratory work related to the contents in 512 101 General Biology I.

512 104 General Biology Laboratory II 1(0-3-0)

* 512 101 General Biology II


Laboratory work related to the contents in 512 102 General Biology II.

513 101 General Chemistry I 3(3-0-6)

Stoichiometry. Atomic structure and properties of the elements in the

periodic table. Chemical bonding. Gases. Solids. Thermodynamics.

513 102 General Chemistry II 3(3-0-6)

Prerequisite :

22

513 101 General Chemistry I

Liquids and solution. Chemical equilibrium and ionic equilibrium.

Electrochemistry. Chemical Kinetics. Introduction to organic chemistry.

513 220 Physical Chemistry 3(3-0-6)

Prerequisite :

(1)

511 102 Calculus II

513 102 General Chemistry II

or (2)

513 102 Mathematics for Biological Science Students


Thermodynamics of gas and solution. Chemical equilibrium and ionic

equilibrium. Electrolytic solution. Chemical kinetics. Macromolecules. Principles

of nuclear chemistry and biological applications. Electromagnetic radiation and

matters.

513 250 Organic Chemistry 3(3-0-6)

Prerequisite :


Chemistry of aliphatic compounds. Aromatic compounds and compounds

with polyfunctional groups. Carbohydrates. Amino acids. Proteins and liquids.

Introduction to ultraviolet and infrared spectroscopies.

514 101 General Physics I 3(3-0-6)

Mechanics of particles and rigid bodies. Properties of matter. Fluid

mechanics. Kinetic theory of gases. Thermodynamics. Vibrations and waves.

514 102 General Physics II 3(3-0-6)

Electricity. Introduction to electronics. Optics. Special theory of relativity

and quantum physics.

514 105 General Physics Laboratory for Pharmacy Students 1(0-3-0)

23

Prerequisite :

514 101 General Physics I

* 514 102 General Physics II


Experiments for pharmacy students related to the contents in 514 101

General Physics I and 514 102 General Physics II.

17.6.2.2 Pharmacy Core Courses

550 102 Basic Pharmaceutical Laboratory 1(0-3-0)

Basic pharmaceutical laboratory techniques in biopharmacy,

pharmaceutical technology, pharmaceutical chemistry and natural products.

550 151 Pharmacy Orientation 1(1-0-2)

An introductory course for pharmacy students about history of pharmacy,

professional ethics; structure of pharmaceutical curricula in Thailand; roles of

pharmacists in various areas of concentration, both in government and private

sectors; inter-relationship among professions in public health; pharmaceutical

literatures.

550 201 Safety of Foods and Drinking Water 3(1-6-2)

Pre-requisite : 561 203 Biopharmacy V

Useful components of food, contaminants in food and water, food

containers, quality control standards of food and water, related methods of

analysis, emphasizing consumer protection stated in related rules and

standards.

550 202 Nutrition and Nutritional therapy 2(2-0-4)

Pre-requisite : 561 202 Biopharmacy IV

Nutrients, daily needs and allowances, energy utilization and

conservation, appropriate and proper nutrition for patients suffering from cardiac

diseases, diabetis mellitus, obesity and others; malnutrition, preventives and

treatments.

24

550 203 Pharmaceutical Quality Control IV 2(2-0-4)


Quality control and assurance of pharmaceutical products utilizing

biological methods, emphasizing micro-bioassays of antibiotics, vitamins, and

others, determination of bioavailability, general toxic effects and sterility.

550 204 Pharmaceutical Quality Control Laboratory IV 1(0-3-0)

Pre-requisite : 550 203 Pharmaceutical Quality Control IV *

*can be co-requisite

Laboratory study of pharmaceutical quality control utilizing biological

methods, including micro-bioassays of antibiotics, vitamins, and others,

determination of bioavailability, general toxic effects and sterility.

550 205 Drug Biotransformation I 3(3-0-6)

Pre-requisite : 562 321 Biopharmaceutics & Pharmacokinetics

Transformation of drugs in the body, phase I, phase II and enzymes

involving in drug biotransformation, oxygen and transformation of drugs and

substances, extrahepatic biotransformation of drugs, biotransformation pathways

and mechanisms of drug in various dosage forms.

550 206 Drug Biotransformation II 3(3-0-6)

Pre-requisite : 550 205 Drug Biotransformation I

Physiological and pathological factors affecting drug biotransformation,

induction and inhibition, drug biotransformation resulting in drug-drug interaction,

drug-substance or drug-food interaction, application of drug biotransformation in

drug formulation, pharmacokinetics, and evaluation of drug therapy.

550 207 Nutrition and Drug Interactions 2(2-0-4)

Pre-requisite : 562 321 Biopharmaceutics and Pharmacokinetics

Study of food-drug interaction effects including effects of drug on food

metabolism and requirement in patient, and effects of patient nutrition on drug

metabolism.

25

550 208 Nutritional Assessment 2(1-3-2)

Pre-requisite : 561 202 Biopharmacy IV

Evaluation of nutrition status in individuals; view on food intakes,

biochemical and clinical measurements, and body size index, including disease

and malnutrition prevention.

550 209 Minerals and Vitamins in Nutrition 2(1-3-2)

Pre-requisite : 561 102 Biopharmacy II

Minerals and vitamins; novel data of usable food sources, nutritional value

and requirements, effects of malnutrition and overuptake, including content

analysis in food.

550 210 Immunopathology 3(3-0-6)


Immunological pathology involve in systemic functions and autoimmune

disease.

550 211 Medical Equipment and Accessories 2(1-3-2)

Medical equipment and accessories, with emphasis on their usage,

handling, and storage.

550 212 Intravenous Admixture 2(1-3-2)

Pre-requisite : 567 224 Pharmaceutical Technology IV

Preparation of intravenous admixture, focusing on preparation process,

incompatability, stability, and concepts in establishing the services for

intravenous admixture and parenteral nutrition in the hospital.

550 213 Radiopharmaceuticals 2(2-0-4)

Radioactive agents, safety and toxicity, preparations and use of

radiopharmaceutical products diagnosis for treatment in pateints.

26

550 214 Hospital Pharmacy 4(3-3-6)

Administrative systems and organizations of pharmaceutical services in

various accredited institutes of health services including hospitals, health service

centres and others, emphasizing on professional practice and duties of

personnels engaging in pharmaceutical services of different administrative levels

and size of hospitals.


Pre-requisite : 080 144 Principles of Research

563 251 Basic Public Health

Study of drug consumers' behavior by using concepts of epidemiology ;

including evaluation of effectiveness based on socioeconomic status and culture

; rational use of drugs, individual and social impact, as well as preventive

measures and problem solving.


Pre-requisite : 563 255 Basic Pharmacy Administrations II

Application of economic concepts in health services, pharmaceutical

activities, drug system and pharmaceutical products; emphasizing on human

resource management policy, pharmaceutical industry, marketing, and price

regulation ; economic evaluation methods of health care and services.

550 217 Environmental Clinical Toxicology 3(1-6-2)

Pre-requisite : 565 243 Toxicology

Environmental pollution with emphasis on etiology, pathophysiology,

impact on human and animal health, and ecological system ; threshold limits,

prevention, and management of toxicant exposure also addressed.

550 218 Veterinary Pharmaceutical Products 3(2-3-4)


Veterinary pharmaceutical products including commercially available

medications, indications, uses, dosage calculation, precaution and

27

contraindication, drug interaction, storage, as well as residual test ; law and

legislation related to veterinary medicines.

550 219 Environmental Toxicology 4(3-3-6)


Effects of environmental chemical contaminants on living beings,

emphasizing potential causes and incidences, phenomena, safety limits and

ecological environments.

550 220 New Drugs and Current Drugs 2(2-0-4)

Pre-requisite : 565 242 Pharmacology II

New drug development and comparative evaluation with currently

available products on pharmacokinetics, pharmacodynamics, therapeutic

indication, dosage form and administration, adverse reaction and drug

interaction.

550 221 Applied Pharmacognosy 2(2-0-4)


566 211 Pharmacognosy II

Application of pharmacognostic knowledge for current use of medicinal

plants in Thailand emphasizing on products frequently used in the country:

integration of both modern medical knowledge and indigeneous knowledge ;

selection of appropiate information and rational counselling based on scientific

evidences.

550 222 Molecular Biotechnology for Pharmacists 3(3-0-6)

Pre-requisite : 561 211 Biological Products

Principles of molecular biotechnology, recombinant DNA technology,

molecular biology researches, regulation of gene expression, synthesis of

various proteins, protein engineering, product engineering for use in therapy,

prevention and diagnosis in primitive and higher cells; including biotechnology

application in therapy.

28

550 223 Pharmaceutical Quality Control III 4(2-6-4)

Pre-requisite : 564 231 Pharmaceutical Quality Control II

Principles and advanced techniques in pharmaceutical analysis focusing

on the application of sophisticated instruments.

550 224 Pharmaceutical Quality Control of Food and Cosmetics 4(3-3-6)


Quality control of food and cosmetics by identification and quantitative

analysis of active ingredients and impurities.

550 225 Biomedical Analysis 4(3-3-6)


Principles, techniques and methods of the quantitative analysis of drugs

and/or their metabolites in biological fluids, focusing on inquisition, data

evaluation, planning and developing of analytical process.

550 226 Pharmaceutical Chemistry Analysis of Dietotherapeutics 3(2-3-4)


Compositions of the substances used in dietotherapeutics in the aspects

of sources, storage, quality control and analysis and uses of special techniques

in determination of stability index as well as identification and determination of

other ingredients

550 227 Mutation Evaluation of Drugs and Envirommental Toxic

Substances 3(1-6-2)


Mutagenicity test and evaluation of drugs and environmental toxicants

employing both current and new protocols and techniques; rationale and

necessity of the investigation are discussed as well.

550 228 Basic Cellular and Molecular Pharmacology 3(3-0-6)


Basic topics in cellular and molecular mechanism of drug actions covering

receptor structure and function, intracellular communication and signal

29

transduction pathways, functional characterization of signaling molecules and

target cell response and effector mechanisms.

550 229 Experimental Pharmacology 2(0-6-0)

Pre – requisite : 565 261 Pharmacology Laboratory I

Basic principles of experimentation in pharmacology covering basic

techniques and protocols for studying in cellular and molecular levels, animal

models for studying drug actions in particular diseases and clinical trials.

550 230 Separation Technique in Pharmaceutical Sciences 3(2-3-4)



Separation of bioactive and valuable compounds from medicinal plants for

analyze, identification, structure elucidation and production process

development.

550 231 Indigenous Medicines 4(3-3-6)



Uses of finish-produced indigenous medicines in rural areas, conceptual

thinkings and trends of people in general on indigenous medicines, local and

modernized pharmaceutical galenical formulations, preparations and evaluations

of indigenous medicines ; applications of phytochemical techniques in analyses.

550 232 Agropharmaceutical Sciences 4(3-3-6)

Pre-requisite : 566 211 Pharmacognosy II

Chemical and pharmaceutical agents used in agriculture and

agroindustries, including insecticides, rodenticides, pesticides, auxins and others

of agroindustrial interests, pharmaceutical therapeutics in veterinary sciences,

animal foodstuffs, fertilizers, fungicides, herbicides; roles and interrelationship of

people in agriculture and agro-industries with pharmacists working in rural

areas.

30

550 233 Biotechnology of Medicinal Plants 3(2-3-4)

Application of biotechnology for production of medicine/ bioactive

compounds, setting up operation and culturing room, preparation of culturing

medium, sterile materials and containers ; techniques and factors affecting the

production including application of genetic engineering techniques ;

development and storage of cell lines.

550 234 Novel Drug Delivery System 2(2-0-4)

Pre-requisite : Senior standing

Novel drug delivery system, focusing on techniques and preparation of

stable products with high productivity.

550 235 Cosmeticology 4(2-6-4)

Pre-requisite : 567 223 Pharmaceutical Technology III

Principle and techniques of cosmeticology including flavor, color and

stability of all cosmetic products; preparation techniques, safety evaluation,

selection and quality control of cosmetic products.

550 236 Manufacturing Management 4(3-3-6)

Organizational management in pharmaceutical industrial firms, production

planning and controling, personnel administration; including purchasing,

distributing and storing system, as well as mechanical system.

550 237 Quality Control and Quality Assurance Systems 4(3-3-6)

Planning of operation in quality control and assurance system in

pharmaceutical industrial firms covering raw materails unto finished

pharmaceutical products; planning of management by using various appropriate

models; principles and conceptual aspects of good professional manufacturing

practice.

31

550 238 Tablet Coating 3(2-3-4)

Pre-requisite : 567 221 Pharmaceutical Technology II

Advanced technology and arts of tablet coating especially sugar coating

and film coating, including principles and techniques of preparation, evaluation

and standardization of dosage forms, process development and problem

solving.

550 239 Introductory Polymer Sciences in Pharmacy 2(2-0-4)

Pre-requisite : 567 225 Pharmaceutical Technology V

Basic knowledge and physico-chemical properties of medical polymer

both in the solution and solid state covering technology of polymer modification

and the application of novel polymer for medical usage.

550 240 Industrial Hygiene 4(3-3-6)

Industrial hygiene of employers and employees in pharmaceutical

industry, preventive measures and precautions of dangers and hazards from

accidents, physico-chemical factors and neuropsychological factors on bodily

and mental healths of employees; hygiene and industrial health services, laws

and regulation, recreations and social welfares.

550 241 Community Pharmacy 3(2-3-4)

Pre-requisite : 563 251 Basic Public Health

Concepts and trends of community pharmacy management in the world

; application of management process in constructing and operating drugstores.

550 242 Public Health Pharmacy 3(2-3-4)


Concepts of administration and innovations of health system ;

development and trends of public health in the world, including practicing skill

for problems solving.

32

550 243 Pharmacists and Rural Health Care 4(2-6-4)


Roles of pharmacists in health problem solving in rural areas ; correlation

of health problems and other rural problems, emphasizing on rural areas in

western region of Thailand.

550 244 Drug Marketing and Detailing 3(2-3-4)

Pre-requisite : 550 366 Pharmacotherapeutics II

563 255 Basic Pharmacy Administrations II

Concepts, principles, theories, procedures and other relevant dynamic

factors concerning management of pharmaceutical marketing; socio- economics

implications of marketing and detailing activities, business administration and

higher detailing techniques including policy planning, operating plans and

various aspects of development and control of medical representations.

550 251 Professional Practice I 1(0-3-0)

Course Evaluation : S/U

Pre-requisite : 3rd year students

Undergraduate practice to experience professional roles in various areas

of pharmacy.

550 301 Special Problems in Pharmaceutical Sciences 3(2-3-4)


Theoretical and laboratory studies of problems in biopharmacy,

pharmacology and toxicology, pharmaceutical chemistry, pharmacognosy and

pharmaceutical technology.

550 306 Current Topics in Pharmaceutical Sciences 2(2-0-4)


Academic advancements of interests in pharmaceutical sciences.

550 307 Advanced Biopharmacy 3(3-0-6)


33

Biopharmaceutical aspects in normal and pathological states, emphasizing

on chemotherapy, metabolism, mechanism of biological changes; principle of

evaluation, including practical guidelines and factors affecting chemotherapy.

550 311 Drug Information in Pharmaceutical Care 3(2-3-4)

Pre-requisite : 565 352 Pharmacotherapeutics I

Drug information sources in pharmaceutical care and drug information

services for pharmacists healthcare professionals, patients, and public;

management of drug information in pharmaceutical care.

550 312 Current Topics in Pharmacy Practice 4(3-3-6)

Pre-requisite : 562 361 Pharmacy Practice

Keeping up-to-date with recent knowledge in pharmacy practice

concerning disease management, pharmaceutical care, recent research;

discussion of new concepts based on research evidence in pharmacy practice.

550 315 Advanced Biopharmaceutics 3(2-3-4)


Factors affecting the rate and amount of drug entering the body from

various pharmaceutical products, consequences of drug administration via

different routes; influences of dosage and dosing interval on the rate and

amount of drug entering the body; study focusing on the recent development in

this field.

550 316 Clinical Pharmacokinetics 2(1-3-2)


Application of pharmacokinetics in adjusting dosage regimen;

therapeutic drug monitoring in individual patients, measuring and interpreting

drug concentration in blood and biological fluids, assessing risk of toxicity of

drug dosage.

34

550 317 Evidence Base in Pharmaceutical Care 3(2-3-4)


Basic concepts and principles of drug therapy based on research

evidence ; research methodology and statistics in clinical research ; retrieval

and critical appraisal of research evidence.

550 318 Outcomes Drug Assessment 3(2-3-4)


Assessment of treatment outcomes in terms of quality of life and

economic aspects; application in evaluating healthcare services and

pharmaceutical products.

550 319 Drug Assessment 2(1-3-2)


Drug development process and clinical trials with the emphasis on data

management and evaluation.

550 320 Drug use Evaluation I 3(2-3-4)


Evaluation of drug use with respect to therapeutic values, indication,

dosage regimen; assessing drug utilization in terms of amount and cost;

measuring and evaluating efficacy and safety of drug treatment, focusing on

basic drug groups with high impacts on health and public health system.

550 321 Drug use Evaluation II 3(2-3-4)


Extended study of drug use evaluation emphasizing on the use of drugs

with serious adverse effects.

550 322 Pharmaceutical Synthesis 3(2-3-4)

Pre-requisite : 564 212 Pharmaceutical Chemistry III

Techniques used in drugs synthesis, reaction control, quantitative analysis

and identification of synthesized products

35

550 324 Evaluation of Drug Action 2(2-0-4)


Study of new drugs emphasizing on drug action, drug efficacy and

adverse reactions by comparing with currently available drugs with similar

mechanism of actions and therapeutic indication; clinical trials and

postmarketing evaluation are also discussed.

550 325 Pharmacology of Neuropsychoactive Drugs 4(3-3-6)


Therapeutic and other pharmacological agents with specific actions or

side-effect actions as neuropsychological agents, narcotic and social addictives,

and hallucinogenics, their toxic and hazardous effects, appropriate and specific

treatments; public health problems relating to such agents, health education and

preventive measures.

550 326 Pharmacology of Cardiovascular Drugs 3(2-3-4)


Academic advancement in cardiovascular drugs including cellular and

molecular pharmacology and natural product development for cardiovascular

diseases; evaluation of current uses and problems related to cardiovascular

drugs.

550 327 Pharmacology of Gastrointestinal Drugs 3(2-3-4)


Academic advancement in gastrointestinal drugs including cellular and

molecular pharmacology and natural product development for gastrointestinal

diseases; evaluation of current uses and problems related to gastrointestinal

drugs.

550 330 Clinical Pharmacology 3(2-3-4)


Basic clinical pharmacology, rational use and selection of drugs for

therapeutic indication with relevance to pharmacokinetics/ pharmacodynamics

consideration, adverse drug reactions and interactions.

36

550 331 Pharmaceutical Packagings 2(2-0-4)

Properties, advantages and disadvantages of materials used for

pharmaceutical packagings, including evaluation and storage.

550 332 Pharmacy Law 1(1-0-2)

Drug law and regulations related to pharmaceutical practices ;

responsibility of pharmacists to consumers and society; application of law

concepts to solve the problems in case studies.

550 333 Evidence Base Phytotherapy 2(2-0-4)



Evaluation and analysis of efficiency and efficacy of medicinal plants and

products derived from medicinal plants for therapeutic and health promotion

purposes based on scientific knowledge including complementary medical

concepts emphasizing on medicinal plants and pharmaceutical products of

medicinal plants available in Thailand.

550 334 Current Therapy in Pharmaceutical Care 4(3-3-6)


Keeping up-to-date with the recent knowledge in pharmaceutical care,

presentation and discussion of present concepts concerning the advancement in

pharmacotherapy.

550 338 Principle of Medicinal Chemistry 3(3-0-6)


565 242 Pharmacology II

Process and the method of structure elucidation of compounds used as

drugs by the application of organic chemistry, biochemistry and pharmacology,

including metabolism, process and chemical mechanism involving the structure

change.

37

550 340 Drug Designs 4(3-3-6)



Integrated knowledges of structure and activity relationships in designing

new drugs with desired physical, biological and pharmacokinetic/dynamic

properties, using computer application.

550 343 Advanced Pharmacology and Toxicology 3(3-0-6)


565 243 Toxicology

Integrated concepts, research, and experimental approaches in

investigative pharmacology as well as biochemical toxicology of drugs/

compounds affecting functions of endocrine system, cardiovascular and renal

system, autonomic and central nervous systems, emphasizing on the levels of

drug/compound-receptor interaction and intracellular signal transduction

pathways.

550 347 Research and Development in Medicinal Plants 3(2-3-4)

Pre-requisite : 080 144 Principles of Research



Systematic study and research, compilation and development of data of

medicinal plants used in Thai remedies.

550 349 Pharmaceutical Formulation and Development 4(2-6-4)


Principle and technique for improvement of the physical properties and

biological action of dosage forms, as well as preparation techniques.

550 351 Professional Practice II 3(0-9-0)


Pre-requisite : with the consent of the faculty

38

A continuity of professional practice emphasizing major areas of hospital

pharmacy, industries, public health institutes, community services, including

other accredited institutes affiliated with pharmaceutical sciences.

550 352 Professional Practice III 5(0-15-0)


Pre-requisite : Senior standing and with consent of the faculty

A continuity of professional practice emphasizing on pharmaceutical care

or pharmaceutical sciences or pharmaceutical informatics.

550 355 Pharmaceutical Biotechnology 3(2-3-4)


Integrated study and application of gene, protein, genetic engineering,

biotechnology, nanotechnology and drug delivery systems in the production of

pharmaceuticals and cosmetics.

550 356 Pharmacogenomics 2(2-0-4)


Integrated study of genetic differences in individuals on the susceptibility

of diseases, drug responses, drug adverse effect and toxicity, emphasizing on

the research and development of drugs for efficient therapy of individuals.

550 359 Computer in Pharmacy 3(2-3-4)

Principles of major components of computer system, hardware and

softwares co-functions; concepts of data evaluation, programming and inventory

controls; application of computer in pharmacy with an emphasis on industrial

pharmacy, hospital pharmacy and community pharmacy.


Data-integrated programs in pharmaceutical applications; emphasis on

drug store and database administration, librarian printed documents in health

sciences and related fields, electronic communication, drug information systems,

sources of pharmaceutical information and problem solving on computerized

39

and database basis; including database development in pharmaceutical

sciences.

550 361 Seminar in Pharmaceutical Sciences 1(0-3-0)


Searching and compiling data in pharmaceutical sciences, analysis of

information collected for presentation and discussion.

550 362 Drug Information Services 3(2-3-4)


Study and practice of drug information service covering searching and

evaluating drug information sources, critically appraising the literature; data

management system; communication skills.

550 363 Consumer Protection in Foods and Drugs 3(2-3-4)

Pre-requisite : 550 332 Pharmacy Law

563 251 Basic Public Health

Concepts, policy, plans and regulation in consumer protection;

consumers' right, implementation in public and private sectors, pharmacists' role

in consumer protection; strategic plans with an emphasis on foods, drugs and

health products.

550 364 Special Problems in Community Pharmacy 3(2-3-4)


563 255 Basic Pharmacy Administrations II

Problem solving in pharmaceutical practice emphasizing retail pharmacy,

marketing, display advertising, and interrelationship between pharmacists and

community.

550 365 Advanced Clinical Pharmacy 4(3-3-6)


In depth and integrated study and practice of clinical pharmacy

concerning drug information service, pharmacy counselling, therapeutic drug

40

monitoring, dietotherapy, practice in patient wards, interpretation of laboratory

results, drug therapy monitoring, preparation of intravenous admixture and toxic

drugs.

550 366 Pharmacotherapeutics II 4(3-3-6)

Pre-requisite : 565 241 Pharmacology I


Basics of pathophysiology, etiology, and drug therapy in the diseases

and disorders of genitourinary system, respiratory system, endocrine system,

cardiovascular system, gastroenterology system, electrolyte balance, and

infectious diseases, with the emphasis on integrated study and practice in drug

therapy monitoring employing case studies and visit to practice sites.

550 367 Pharmacotherapeutics III 4(3-3-6)



Pathophysiology and pharmacotherapy of musculoskeletal disorders,

hematological, immunological, neurological, psychological, dermatological, eye-

ear-nose-throat, obstetric-gynecological, cancer diseases ; rational uses of

drugs in pediatrics, pregnancy and geriatrics, integrated problem solving and

plan for rational drug use and monitoring, including problem-solving skills in

clinical settings.

550 368 Public Health Administration 3(2-3-4)


Approaches in public health administration, structure, policy and

strategy of health system development; obstructions in implementation and

administration process; development in public health pharmacy especially in

hospital and health centers.

550 369 Special Problems in Pharmaceutical Care 2(1-3-2)


Problems concerning pharmaceutical care focusing on pharmacotherapy.

41

550 370 Research and Development of Pharmaceutical Products 2(2-0-4)


Research and development processes of pharmaceuticals, cosmetics,

biological products and herbal medicine, including pharmacology and toxicology

of drugs, structural and dosage form designs, as well as clinical assessment.

550 371 Management in Pharmaceutical Sciences 2(2-0-4)


Planning, personnel management, purchasing and storing system, as well

as clinical assessment for research and development of pharmaceutical

products.

550 372 Quality Assurance in Pharmaceutical Sciences 3(3-0-6)

Concepts of quality assurance in pharmacy focusing on national and

international standards, conceptional agreements and regulations.

550 373 Communication and Health 3(1-6-2)



Communication skills with patients and health care professionals in

pharmacy practices.

550 374 Strategy in Pharmacy Administration 3(2-3-4)


Strategy in pharmacy management emphasize on organization and

personnel management, small and medium enterprises, inventory control,

financial and cost accounting; including managerial costing for evaluation and

decision making.

550 375 Pharmaceutical Information Management 3(2-3-4)

Pharmaceutical specialties available in drug information, searching

from primary, secondary and tertiary sources, categorization, evaluation, data

management, and provision ; analysis of drug information from leaflets and

42

other sources; presentation techniques, as well as law and ethics in

management of pharmaceutical information.

550 399 Senior Project 1(0-3-0)

Pre-requisite : Senior standing and 080 144 Principles of Research

Preparatory programme for Pharmacy students to achieve higher

standard of scholastic pharmacists to serve in various organizations and

regions, emphasizing on team working for problem solving, administration of

information system, pharmaceutical and medical inventory administration,

production and quality control, and academic services to community.

561 101 Biopharmacy I 2(2-0-4)

Pre-requisite : 512 102 General Biology II

Integrated study of cell structures, properties and functions of cell

organelles, methods in biochemistry, structures and functions of biomolecules in

normal and pathological states.

561 102 Biopharmacy II 2(2-0-4)

Pre-requisite : 561 101 Biopharmacy I

Metabolism of biomolecules, principle of nutrition, integrated study of

cell biology with special emphasis on cell function and molecular signelling.

561 103 Basic Molecular Biology for Pharmacists 1(1-0-2)


Basic principles in molecular biology and genetics; structure and function

of genes and chromosomes, molecular controlling, principle aspects of genetic

engineering in pharmaceutical applications.

561 131 Biopharmacy Laboratory I 1(0-3-0)

Pre-requisite : 550 102 Basic Pharmaceutical Laboratory

561 101 Biopharmacy I *

* can be co-requisite

Laboratory practice to understand basic techniques and contents related

to 561 101 Biopharmacy I.

43

561 201 Biopharmacy III 3(3-0-6)

Pre-requisite : 561 101 Biopharmacy I

Integrated anatomical, biochemical and physiological study of structures,

functions and interaction of human cells, tissues and organ system in normal

state ; emphasizing on nervous system, musculoskeletal system, endocrines,

and reproductive system.

561 202 Biopharmacy IV 2(2-0-4)

Pre-requisite : 561 201 Biopharmacy III

Integrated study of anatomical, biochemical and physiological controls of

structures, functions and interaction of human cells, tissues and organ system in

normal state ; emphasizing on hematology, cardiovascular, urinary, respiratory

and gastrointestinal systems, including homeostasis.

561 203 Biopharmacy V 4(4-0-8)


Biochemical and physiological aspects of pathogenic microorganisms,

preventives, principles and techniques of asepsis, immunity, parasitic

infestations in man and animals, animal-born diseases, identification of

microorganisms and tests of susceptibility towards medicines, application of

microorganisms in pharmaceutical interests, also covering other principle

aspects and techniques in pharmaceutical microbiology, parasitology and

immunology.

561 211 Biological Products 2(2-0-4)


Origins, preparations and standardization, utilization and precautions of

biological products including vaccines, sera, toxoids, allergenics, anti-venoms,

anti-rabies and others; related biotechnological methods, laws and regulations

concerning utilization and controls of such products.

561 231 Biopharmacy Laboratory III 1(0-3-0)

Pre-requisite : 561 201 Biopharmacy III *

44


Laboratory practice to understand basic techniques in physiology and

contents related to 561 201 Biopharmacy III.

561 232 Biopharmacy Laboratory IV 1(0-3-0)

Pre-requisite : 561 202 Biopharmacy IV *


Laboratory practice in biochemical and physiological regulatory systems of

cells, tissues and organs; with contents related to 561 202 Biopharmacy IV.

561 233 Biopharmacy Laboratory V 1(0-3-0)

Pre-requisite : 561 203 Biopharmacy V *


Laboratory practice in biochemical and physiological aspects of

pathogenic microorganisms, preventives, principles and techniques of asepsis,

immunity, parasitic infestations in man and animals, identification of

microorganisms and tests of susceptibility towards medicines, application of

microorganisms in pharmaceutical interests, also covering other principle

aspects and techniques with contents related to 561 203 Biopharmacy V.

562 321 Biopharmaceutics and Pharmacokinetics 3(3-0-6)

Pre-requisite : 565 242 Pharmacology II *


Effects of physical and chemical properties of drug, biological and other

factors on dynamics and kinetics of drug absorption, distribution, metabolism,

and excretion; bioavailability; mathematical models; the application of

pharmacokinetic principles in assessing pharmaceutical products regarding

pharmacological and pharmacotherapeutic aspects.

562 361 Pharmacy Practice 4(3-3-6)


Basic concepts and principles in clinical pharmacy covering documentary

system and essential parameters in pharmaceutical care, with the emphasis on

identifying, correcting, and preventing drug-related problems.

45

563 254 Basic Pharmacy Administrations I 2(2-0-4)

Fundamental principles of management in public and private sectors,

types of business, risk management and insurances ; basic principle of

economics and its application in pharmacy administration.

563 255 Basic Pharmacy Administrations II 2(1-3-2)

Pre-requisite : 563 254 Basic Pharmacy Administrations I

Application of managerial accounting , cost and strategy in administration

of pharmacy services.

564 111 Pharmaceutical Chemistry I 1(1-0-2)

Pre-requisite : 513 102 General Chemistry II

Sources, pharmaceutical preparations, identification, purification and purity

rubrics, limit test, therapeutic uses, precaution and storage of inorganic

pharmaceutical compounds.

564 121 Pharmaceutical Chemistry Laboratory I 1(0-3-0)

Pre-requisite : 564 111 Pharmaceutical Chemistry I *


Laboratory in pharmaceutical preparation, identification, purification,

therapeutic uses, precaution and storage of inorganic and organic

pharmaceutical compounds.

564 131 Pharmaceutical Quality Control I 3(3-0-6)

Pre-requisite : 513 102 General Chemistry II

Fundamental and integrated knowledges of physical control of raw

materials and pharmaceuticals, including principles and qualitative analytical

techniques involving various physical analytical methods, emphasizing analysis

and interpretation in pharmacy.

564 132 Pharmaceutical Quality Control Laboratory I 2(0-6-0)

Pre-requisite : 550 102 Basic Pharmaceutical Laboratory

564 131 Pharmaceutical Quality Control I*


46

Quality control laboratory of raw materials and pharmaceuticals according

to pharmacopoeias by various analytical methods which conform to the contents

in 564 131 Pharmaceutical Quality Control, emphasizing analysis and

interpretation in pharmacy.

564 211 Pharmaceutical Chemistry II 3(3-0-6)

Pre-requisite : 513 250 Organic Chemistry

Organic pharmaceutical and medicinal compounds from synthesis,

pharmaceutical therapeutics, structure-activity relationships of pharmaceuticals,

stability, purity, identification, principles and techniques of pharmaceutical

syntheses covering those compounds employing in neuromuscular,

cardiovascular and nephrotic system.

564 212 Pharmaceutical Chemistry III 4(4-0-8)

Pre-requisite : 564 211 Pharmaceutical Chemistry II

Pharmaceutical chemistry of synthetic compounds employing as

antibiotics, hormones, anti-inflammatory drugs, antineoplastics and other

categories.

564 231 Pharmaceutical Quality Control II 3(3-0-6)

Pre-requisite : 564 131 Pharmaceutical Quality Control I

Pharmaceutical quality control focusing on principles and application of

advanced instrumental analysis in pharmaceutical quality control including

structure elucidation, separation techniques, data analysis and other special

techniques.

564 233 Pharmaceutical Quality Control Laboratory II 1(0-3-0)

Pre-requisite : 564 231 Pharmaceutical Quality Control II *


Laboratory of pharmaceutical quality control emphasizing on practical

approaches of advanced instrumental analysis in pharmaceutical quality control

including structure elucidation, separation techniques, data analysis and other

special techniques.

47

565 241 Pharmacology I 3(3-0-6)



Pharmacological principles and concepts of drugs as therapeutic

agents, indications and contra-indications, side-effects and precautions, adverse

drug reactions, dosage and ulilization, and mechanisms of actions at molecular,

cellular and organ levels in terms of pharmacodynamics, covering therapeutic

agents acting on autonomic and central nervous systems.

565 242 Pharmacology II 4(4-0-8)



Pharmacology of therapeutic agents acting on cardiovascular and renal

systems, gastrointestinal system, respiratory system and those as antibiotics,

antineoplastics, hormones and immunological products.

565 243 Toxicology 2(2-0-4)

Toxicology of therapeutic agents, cosmetics, food additives, hazardous

toxicants, household chemicals, agents used in agriculture, pollutants and

narcotics, covering principles and aspects of mechanisms of actions, antidotal

therapy and treatments, safety measures, methods in qualitative and

quantitative analyses including forensic confirmation analysis.

565 261 Pharmacology Laboratory I 1(0-3-0)

Pre-requisite : 565 241 Pharmacology I *


Laboratory course on therapeutic uses of drugs, precaution and adverse

drug reaction, indications and contraindication, pharmacokinetics

/pharmacodynamics of drugs for autonomic and central nervous system.

565 263 Toxicology Laboratory 1(0-3-0)

Pre-requisite : 565 243 Toxicology *


48

Laboratory course on toxic actions of drugs, cosmetics, food additive,

household products, agricultural products as well as drug of abuse; emphasizing

on toxic symptoms and management; primary analyses as well as forensic

confirmation test of toxicants.

565 352 Pharmacotherapeutics I 3(3-0-6)



Rational use and selection of drugs in various pathological disorders,

including vitamins and food supplement; pharmacogenetic basis of drug

responses; drug use in medical emergency.

566 111 Pharmacognosy I 3(3-0-6)

Pre-requisite : 566 101 Pharmaceutical Botany

Phytochemical study of medicinal plants, including biosynthesis,

decomposition, natural sources, classification of natural compounds from plants,

animals and minerals as well as application in medical and pharmaceutical

purposes.

566 121 Pharmacognosy Laboratory I 1(0-3-0)

Pre-requsite : 566 111 Pharmacognosy I *


Extraction of natural products, screening, analyse, and identification

emphasizing on medicinal plants.

566 211 Pharmacognosy II 2(2-0-4)

Pre-requisite : 566 111 Pharmacognosy I

Extended study of natural products, emphasizing on identification,

standardization, preparation and formulation of natural medicine, plant tissue

culture, and evaluation for medicinal purposes.

566 221 Pharmacognosy Laboratory II 1(0-3-0)

Pre-requisite : 566 111 Pharmacognosy II *


49

Quality control, setting up standardization, identification and preparation

of crude drugs and herbal products, plant tissue culture, and herbal drug

evaluation emphasizing on phytochemistry and pharmacology.

567 221 Pharmaceutical Technology I 2(2-0-4)

Pre-requisite : 550 156 Introduction to Pharmaceutical Dosage

Forms and Technology

Drug dosage forms, introductory Good Manufacturing Practice, physical

properties of materials, including technique of solubilization and solution

properties ; preparation, storage, and stability of solution dosage forms also

discussed.

567 222 Pharmaceutical Technology II 3(3-0-6)



Pharmaceutical powder technology such as size and size distribution,

measurement of particle size, flowability and other properties related to the

preparation of solid dosage forms especially tablets, capsules and coated-

tablets.

567 223 Pharmaceutical Technology III 3(3-0-6)



Basic concepts, preparation techniques, physical properties, formulation

development, and stability of heterogeneous solid, liquid and semisolid dosage

forms.

567 224 Pharmaceutical Technology IV 2(2-0-4)

Pre-requisite : 567 221 Pharmaceutical Technology I

Technology and arts of manufacturing of sterile solid, semi-solid and

solution dosage forms, focusing on injectable dosage forms, eye preparations,

and parenteral dosage forms ; quality control of dosages, Good Manufacturing

Practices, storage, and packaging also concerned.

50

567 225 Pharmaceutical Technology V 2(2-0-4)



Comprehensive study of knowledge and technology for development of

novel dosage forms, aerosols, radiopharmaceuticals, packaging selection and

the application of statistics for products evaluation also included.

567 261 Pharmaceutical Technology Laboratory I 1(0-3-0)

Pre-requisite : 567 221 Pharmaceutical Technology I *


Practicing of technology and arts for development of solution dosage

forms, their quality controls according to pharmacopoeia, packaging selection

and process validation.

567 262 Pharmaceutical Technology Laboratory II 1(0-3-0)

Pre-requisite : 567 222 Pharmaceutical Technology II *


Practicing of technology and arts for development of solid dosage forms

especially tablets and capsules, their quality controls according to

pharmacopoeia, packaging selection and process validation.

567 263 Pharmaceutical Technology Laboratory III 1(0-3-0)

Pre-requisite : 567 223 Pharmaceutical Technology III *


Practicing skill in development of heterogeneous solid, liquid and semi-

solid dosage forms, techniques of preparation and stabilization of dosage forms,

their quality controls according to pharmacopoeia, packaging selection and

process validation.

567 264 Pharmaceutical Technology Laboratory IV 1(0-3-0)

Pre-requisite : 567 224 Pharmaceutical Technology IV *


51

Practicing of technology and arts for development of sterile dosage forms,

including large and small volume parenteral dosage forms ; their quality controls

according to pharmacopoeia, packaging selection and process validation.

18. Quality Assurance

The program will be subjected to standard quality assurance procedure set by the

Ministry of Education.

52

Name Qualification Research

Experience

Work load

For this program

(hours/week)

1. Assoc.Prof. Dr. Sindchai

Keokitichai

B.S.(Pharm) Mahidol (1972)

M.Phil. University of London (1978)

Ph.D. University of London, UK. )1980(

Appendices 1.07

2. Prof.Dr.Vira Kasantikul M.D.Chulalongkorn (1972)

Residency Anatomic Pathology : Vanderbilt

University. (1978)

Fellowship Neuropathology : University of

California at Los Angeles, USA. (1982)

Appendices 0.80

3. Ms.Chantana

Wessapan

B.Pharm. Chiang Mai University (1979)

M.Sc. (Microbiology) Chulalongkorn

University (1986)

Appendices 7.30

4. Dr.Sunee

Techaarpornkul

B.Pharm. Chinang Mai (1984)

M.Sc. (Microbiology) Chulalongkorn

University (1989)

Ph.D. (Molecular Virology) (2001)

Appendices 5.13

5. Assoc.Prof.Dr.Nusara

Piyapolrungroj

B.Sc.in Pharm. Chulalongkorn University (1986)

M.Sc. (Food Chemistry)

Chulalongkorn University (1990)

Ph.D. (Pharmaceutics) University of

Michigan, USA. (1998)

Appendices 7.23

6. Asst.Prof.Dr.Verayuth

Lertnattee

B.Sc. in Pharm. Chulalongkorn University (1989)

M.Sc. in Pharm. Mahidol University (1991)

M.Sc.(Computer Sciences)


Ph.D. (Information Technology) Thammasat

University (2004)

- -

7. Asst.Prof.Dr.Auayporn

Apirakaramwong

B.Pharm. Chiang Mai (1990)

M.Sc. in Pharm Mahidol University(1992)

Ph.D. (Clinical Biochemistry)

Chiba University, Japan. (1999)

Appendices 8.57

8. Asst.Prof.Paranee

Meetam

B.S.(Pharm) Mahidol University (1990)

M.Sc.Physiology) Mahidol University (1992)

Continuing

for Ph.D.

7.43

Faculty staff

53


Experience

Work load

For this program

(hours/week)

9. Mr.Tosak

Intaraphairot

B.Pharm. Silpakorn University (2534) Continuing for

Ph.D.

Continuing for

Ph.D.

10. Mr.Chatchai

Powthongchin

B.Sc. in Pharm. Chulalongkorn University

(2528)

M.Sc.in Pharm. (Physiology)


Appendices 13.47

11. Dr.Wisit

Tangkeangsirisin

◌B.Pharm. Silpakorn University (2537)

Ph.D. (Pharm Sci) Maryland, USA

(2004)

- -

12. Dr.Siripan

Limsirichaikul

B.Pharm. Khonkhaen University (2535)

M.Sc.in Pharm. Mahidol University (2538)

Ph.D. (Biochemistry)

Chiba University, Japan (2004)

- -

13. Asst.Prof.Busaba

Powthongchin

B.Pharm. Chiang Mai University, (2531)

M.Sc.in Pharm. (Pharmaceutics)


Continuing for

Ph.D.

Continuing for

Ph.D.

14. Dr. Suang

Rungpragayphan

B.Pharm. Silpakorn University (2537)

Ph.D. (Biochemistry)

Chiba University, Japan (2004)

- -

15. Ms. Juree

Charenteeraboon


M.Sc. (Biochemistry) Mahidol University (2544)

Continuing for

Ph.D.

Continuing for

Ph.D.

16. Dr.Sarawut

Nukoolkarn

B.S. (Pharm) Mahidol University (2539)

Ph.D. (Clinical Biochemistry), Mahidol

University (2004)

Continuing for

Ph.D.

Continuing for

Ph.D.

17. Mr. Perayot

Pamornsinlapatham

B.Pharm. Naresuan University (2541) Continuing for

Ph.D.

Continuing for

Ph.D.

18. Mr. Ratpan Ramoon B.Pharm. Silpakorn University (2544)

- -

54


Experience

Work load

For this program

(hours/week)

19. Asst.Prof.Dr.Manat

Pongchaidecha


M. Sc (Clinical Pharmacy) University of

Strathchyde UK(1989)

Ph.D. (Pharmacy) University of

Manchester , UK. (1993)

Appendices 13.45

20. Asst.Prof. Dr.Nalinee

Poolsup

B.S. (Pharm) Mahidol University (1991)

M.Sc. in Pharm. Mahidol University1993

Ph.D. (Evidence base

erapyPharmacoth ) Aston University, UK.

(2000)

Appendices 9.95

21. Asst.Porf.Dr.Watcharee

Leurmarnkul


Ph.D.(Clinical Pharmacy)

University of Wales, Cardiff, UK. (1998)

Appendices 6.16

22. Ms.Intira

Kanchanaphibool


(1989)

M.Sc. (Hospital and Clinical Pharmacy)


Continuing for

Ph.D.

Continuing for

Ph.D.

23. Ms.Surassawadee

Suntharasaj


(1988)

M. cS .in Pharm. Chulalongkorn University

(1993)

Continuing for

Ph.D.

Continuing for

Ph.D.

24. Dr. Monrudee

Sukma


M.Sc. Mahidol University (1996)

Ph.D. (Pharmacology) Toyama , Japan

2003

- -

25. Ms. Juntarutsamon

Dansirikul


M.Sc. Chiang Mai University (1996)

Continuing for

Ph.D.

Continuing for

Ph.D.

26. Ms. Karunrat

Tewthanom


M.Sc.in Pharm. Mahidol University

(1998)

Continuing for

Ph.D.

Continuing for

Ph.D.

55


Experience

Work load

For this program

(hours/week)

27. Ms. Nunthalukna

Sthapornnanon


(1987)

M.Sc. (Hospital and Clinical Pharmacy)

rsityChulalongkorn Unive (1993)

Continuing for

Ph.D.

10.72

28. Asst.Prof.Dr.Numfon

Sivanawin


Pharm.D. University of IIIinois at

Chicago, USA. (1999)

Board Certified Pharmacotherapy

Specialist (BCPS) (2000)

ceCertified Pharmacy Practi

Resident. (2000)

Appendices 9.91

29. Ms.Wilai

Trakoonosot


Ph.D.

Continuing for

Ph.D.

30. Assoc.Prof.Rapeepan

Chalongsuk


(1979)

B.Sc. hamhang Universityin Laws Ramk

(1984)

M.Sc.in Pharm. Chulalongkorn University

(1988) MBA (1993)

Appendices 9.07

31. Asst.Prof.Danita

Phanucharas


(1984)

M.Sc.in Pharm. Chulalongkorn

University (1987)

Appendices 10.11

32. Ms.Yauwalak

Amrumpai


(1986)


Continuing for

Ph.D.

Continuing for

Ph.D.

33. Dr.Pagamas

Maitreemit


(1978)


Ph.D. Mahidol University (2000)

Appendices 8.15

56


Experience

Work load

For this program

(hours/week)

34. Ms.Nattiya Kapol



(1997)

r Continuing fo

Ph.D.

8.39

35. Dr.Burin T.Sriwong


M.S.,Ph.D.University of Wisconsin ,

USA) .2002(

Appendices -

36. Ms.Waranee

Bunchaycher


Ph.D.

4.63

37. Ms.Numfon

Sribundit


MBA. Tumsart University (2000)

Appendices 5.35

38. Mr.Panoopat

Poompruek


Ph.D.

Continuing for

Ph.D.

39. Mr.Surasit

Rojitaumnay

B. mPhar . Silpakorn University (2001) Continuing for

Ph.D.

Continuing for

Ph.D.

40. Asst.Prof.Pensri

Nuengsigkapian


(1978)

M.S. (Radiopharmacy) University of

Southern California, USA. (1981)

Appendices 7.67

41. Asst.Prof.Dr.Onooma

Poobrasert

B.S.(Pharm) Mahidol University (1986)



Ph.D. (Pharmacognosy) University of

Illinois at Chicago, USA. (1997)

Appendices 6.60

42. Assoc.Prof.Lawan

Sriphong


(1986)

M.Sc.in Pharm. (Pharmaceutical

Chemistry) Chulalongkorn University

(1990)

MBA. Thummasart University (1994)

Appendices 8.73

57


Experience

Work load

For this program

(hours/week)

43. Mr.Panjapol

Laopoonpat

B.S. (Pharm) Mahidol University

(1990)

Appendices 7.53

44. Asst.Prof.Dr.Panadda

Yaipakdee


Ph.D. Ohio State University USA.

(1998)

Appendices 7.63

45. Dr.Sathit Niratisai B.Sc. in Pharm. Chulalongkorn

University (1991)

M.Sc.in Pharm.Chulalongkorn

University (1994)

Ph.D. Minnesota, USA (2004)

- -

46. Dr.Kanawan

Pochanakom

B.Pharm. Chiang Mai University

(1988)



(1991)

Dr.rer.Nat. (Pharmaceutical

Chemistry) Bonn, Germany (1999)

Appendices 7.82

47. Asst.Prof.Dr.Chutima

Limmatvapirat


Ph. D).Pharmaceutical Chemisty (

Chulalongkorn University )2000(

Appendices 8.60

48. Dr.Chanokporn

Sukonpan


(1988)


University (1992)

Ph.D. University of Wisconsin, USA.

(2002)

- -

49. Asst.Prof.Jankana

Buranaosot


(1988)

M.Sc.in Pharm. ( aceutical Pharm


(1993)

Appendices 8.40

58


Experience

Work load

For this program

(hours/week)

50. Asst.Prof.Malai

Satirapun

B.Sc. in Pharm. Chulalongkorn

University (1987)

M.Sc.in Pharm. ( rmaceutical Pha


(1992)

Appendices 8.20

51. Dr.Amornrut

Chaidedgumjorn


Ph.D. Chiba University (2001)

Appendices -

52. Mr.Theerasak

Rojanarata

B.Pharm. Silpakorn University ( 5199 ) Continuing for

Ph.D.

Continuing for

Ph.D.

53. Mr.Paibool

Nuntanakorn


University (1992)


University (1996)

Continuing for

Ph.D.

Continuing for

Ph.D.

54. Mr.Kanong

Ruttanakorn

B.Pharm. Naresuan University (2002) - -

55. Dr.Vichien

Leelasagnaluk


University (1981)


(1984)

Ph.D. Chulalongkorn University (1996)

Appendices 7.27

56. Assoc.Prof.Srisombut

Nawanopparatsakul


(1987)

M.Sc.in Pharm. Chiang Mai University

(1990)

Appendices 6.41

57. Asst.Prof.Chatchai

Chinpaisal


University (1990)

Ph.D. (Pharmacology) University of

Minnesota, USA. (1999)

cesAppendi 7.63

58. Ms.Noparat

Nattaratanapong


M.Sc. (Pharmacology) Mahidol

University (1996)

Continuing for

Ph.D.

Continuing for

Ph.D.

59


Experience

Work load

For this program

(hours/week)

59. Dr.Suravut

Watana


University (1988)


University (1992)

Ph.D. University of Wisconsin , USA.

(2003)

- -

60. Mr.Sarayut

Janmahasatian


(1991)

r Continuing fo

Ph.D.

Continuing for

Ph.D.

61. Dr.Patamawan

Phuagphong


(1996)

Ph.D. Osaka, Japan (2004)

- -

62. Ms.Nushjira

Pongnimitprasert



University (1998)

tinuing for Con

Ph.D.

Continuing for

Ph.D.

63. Ms.Waraporn

Sakasawatmakhin


Ph.D.

Continuing for

Ph.D.

64.Asst.Prof.Dr.Wandee

Yanpaisan


(1983)

M.Sc. tyMahidol Universi (1987)

Ph.D.(Biotechnology) University of

New South Wales, Australia (1997)

Appendices 8.33

65. Asst.Prof.Dr.Uthai

Sotanaphun


University (1988)


Botany)


Ph.D )Pharmaceutical Chemistry and

Natural Products (Chulalongkorn

University )1997(

Appendices 12.43

60


Experience

Work load

For this program

(hours/week)

66. Asst.Prof.Sinthop

Chomya

B.Sc. in Pharm. n Chulalongkor

University (1980)


Botany)


Appendices -

67. Ms.Nudchanart

Kitcharoen


University (1987)


University (1993)

Appendices 9.5

68. Dr.Penpun

Wetwitayaklung

B.S.(Pharm) Mahidol University

(1992)

M.Sc.in Pharm. (Pharm. Chem.)


Ph.D. University of Vienna , Austria.

(2001)

Appendices -

69. Dr.Chavalit

Sittisombut

B. Pharm .Chiang Mai University

)1980(

M.Sc.in Pharm. Chiang Mai University

(1989)

Ph.D. (Pharmacognosy) University of

Paris V, France (2003)

- -

70. Ms.Hataiporn

Sirinamarattana


Ph.D.

Continuing for

Ph.D.

71. Ms.Tasmaporn

Sukwattanasinitti


Ph.D.

Continuing for

Ph.D.

72.Assoc.Prof.Dr.

Jurairat Nanthanid


(1980)


University (1986)

Ph.D. (Pharmaceutics) Mahidol

iversityUn (2000)

Appendices 11.20

61


Experience

Work load

For this program

(hours/week)

73. Asst.Prof.Dr.

Wanchai Sutananta


(1983)


(1986)

Ph.D. ( al TechnologyPharmaceutic )

University of London , UK. (1992)

Appendices 2.80

74. Asst.Prof.Dr.

Suwannee

Panomsuk


(1987)


University (1989)

Ph.D.( Pharmaceutics ( Toyama

Medical and Pharmaceutical

University ,Japan )1996 (

Appendices 9.67

75. Assoc.Prof.Dr.Manee

Laungtana-anan


(1983)

M.Phil, Ph.D. Manchester, UK (1989)

Appendices 11.37

76. Asst.Prof.Dr.Sontaya

Limmatvapirat


( 8919 )


University (1991)

Ph.D.(Pharmaceutical Technology)

Chiba University , Japan (1998)

Appendices 10.67

77. Dr.Parichat Chomto B.S.(Pharm) Mahidol University(1990)


University (1992)

Ph. orn UniversityD Chulalongk (2000)

Appendices 5.07

78. Dr.Nutwat Nutpoolwat B.Pharm. Silpakorn University (1992)


(1995)

Ph.D.(Pharmaceutics) Mahidol

University (2001)

Appendices 6.87

62


Experience

adWork lo

For this program

(hours/week)

79. Asst.Prof.Dr.Pornsak

Sriamornsak


(1994)


(1996)

Ph.D. (Pharmaceutics) Charles Sturt

University, Australia ) 2002(

Appendices -

80. Asst.Prof.Dr.Somluk

Kongmuang


University (1988)


University (1991)

Ph.D.(Pharmaceutics) Purdue

University , USA. (1999)

Appendices 10.00

81. Dr.Panida

Asavapichayont


tyUniversi (1984)


University (1987)

Ph.D. (Pharmacy) University of

Saskatchewan, Canada. (2000)

Appendices 4.65

82. Asst.Prof.Dr.

Gaysorn Chansiri


University(1986)


lalongkorn UniversityChu (1988)

Ph.D.(Pharmaceutics) Purdue

University , USA. (1997)

Appendices 10.73

83. Asst.Prof.Dr.

Thawatchai

Phaechamud



University (1995)

Ph.D. (Pharmaceutics) Chulalongkorn

University (1999)

Appendices 10.40

63


Experience

Work load

For this program

(hours/week)

84. Asst.Prof.Dr.

Thanasait

Ngawhirunpat


(1993)

M.Sc. in Pharm. idol UniversityMah

(1995)

Ph.D.(Pharmaceutical Sciences)

Toyama Medical and Pharmaceutical

University, Japan (2002)

Appendices -

85. Ms.Vipaluk

Patomchaiviwat


(1990)


University (1993)

ng for Continui

Ph.D.

Continuing for

Ph.D.

86. Asst.Prof.Prasert

Akkaramongkolporn



(1995)

Continuing for

Ph.D.

Continuing for

Ph.D.

87. Asst.Prof.Dr.

Praneet Opanasopit

B.Pharm. pakorn UniversitySil (1992)


University (1995)

Ph.D.(Pharmaceutics Sciences)

Kyoto University , Japan (2002)

- -

88. Mr.Chalermphon

Wanawongthai


Ph.D.

4.64

89. Dr.Suchda

Wanchana


(1994)


(1998)

Ph.D.(Pharmaceutical Sciences)

Toyama Medical and Pharmaceutical

University, Japan (2002)

- -

62

Appendices

63

Research Experiences

Assoc.Prof.Dr.Sindchai Keokitichai

Research

1. Wrigglesworth, JM;Keokitchai, S;Wooster,MS & Millar, FA "Modificatrtion of

Glyceraldehyde-3-phosphate Dehydrogenase Actiivty by adsorption to

Erythorcyte Membrane and Phospholipid vesicles "563 rd Biochem. Soc.

Meeting, London, UK Vol 4:637-640 (1976)

2. Keokitichai, S & Wrigglesworth, JM "Association of Glyceraldehyde-3 -

phosphate dehydrogenase with the Membrane of the intact Erythrocyte" XI th

International Congress of Biochemistry, IUB, Toronto. Canada. (1979)

3. Keokitichai, S & Wrigglesworth, JM "Association of Glyceraldehyde-3-

phosphate dehydroenase with the Membrane of the Inteact Human Erythrocyte

"Biochem, J. 187-841 (1980)

4. Chen, SM, Keokitichai S & Wrigglesworth JM "Association of Glycolytic

Enzymes with the Erythrocyte Membrane" 592 nd Biochem. Soc. Meeting,

London, UK page 139-140 (1981)

Prof.Dr.Vira Kasantikul

Research

1. Srikiatkhachon A, Anantasethakul T, Phansuwan-Pujito P, Pathumraj

S,Kasantikul V. Effect of serotonin depletion in nitric oxide induced

cerebrovascular nociceptive response. Neuro-Report 2001; 12: 967-971.

2. Achavanuntakul B, Eiam-Ong S, Tantawichien T, Nualboonma P, Kasantikul V.

Exchange transfusion in severe falciparum malaria: a simple method modified

from hemodialysis circuit. J Med Assoc Thai 2001;84:314-322.

3. Kasantikul V. Motorcycle accident causation and identification of

countermeasure in Thailand. Vol. 1 : Bangkok study, 2001, 322 pp

4. Kasantikul V. Motorcycle accident causation and identification of

Countermeasure in Thailand. Vol. II : Upcountry study, 2001, 309 pp.

5. Piyavisetpat N, Pantongrag-Brown L, Kasantikul V. CT features of adult ilms’

tumor: a case report. Chula Med J 2002; 46: 65 – 71.

Mr.Perayot Pamornsinlapatham

Research

1. Quan, C.P., Watanabe, S., Pamonsinlapatham, P., Bouvet, J.P. (2001). Different

dysregulations of the natural antibody repertoire in treated and untreated HIV-1

patients. Journal of Autoimmunity :(in press).

64

Assoc.Prof.Dr. Nusara Piyapolungroj

Research

H. A. Apirakaramwong, and N. Piyapolrungroj (2002): Effect of antimicrobial supplement on

drug transport across Caco-2 monolayer (in Thai). Srinakharinwirot Journal of

Pharmaceutical Sciences 7:30-40.

I. N. Piyapolrungroj, and V. Leelasangaluk (2002): Effect of H2-antagonists on Paracellular

Drug Absorption. The Thai Journal of Pharmaceutical Sciences 26:45-51

J. A. Apirakaramwong, and N. Piyapolrungroj (2002): Effect of Antimicrobial Supplement on

Caco-2 Cells. The Thai Journal of Pharmaceutical Sciences 26 (Suppl.):28.

K. S. Kongmuang, and N. Piyapolrungroj (2002): Effect of Solubilizer for Riboflavin on

Caco-2 Cell Monolayer Morphology. The Thai Journal of Pharmaceutical Sciences 26

(Suppl.):53.

L. N. Piyapolrungroj, C. Li, H. Bockbrader, G. Liu, and D. Fleisher (2001): Mucosal Uptake

of Gabapentin (Neurontin) vs. Pregabalin in the Small Intestine. Pharmaceutical

Research 18:1126-1130.

Dr.Sunee Techaarpornkul

Research

1. Techaarpornkul, S., Barretto, N., and Peeples, M.E. (2001). Functional analysis of

recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and

/or attachment glycoprotein gene. J. Virol. 75(15).

Asst.Prof.Dr.Auayporn Apirakaramwong

Research

1. Raj, V.S., Tomitori, H., Yoshida, M., Apirakaramwong, A., Kashiwagi, K., Takio, K.,

Ishihama, A., and Igarashi, K. (2001). Properties of a revertant of Escherichia coli viable

in the presence of spermidine accumulation: increase in L-glycerol 3-phosphate. J.

Bacteriol. 183:4493-4498.

2. Apirakaramwong, A., Kashiwagi, K., Raj, V.S., Kasata, K,. Kakinuma, Y., Ishihama, A.,

and Igarashi, K. (1999). Involvement of ppGpp, ribosome modulation factor, and

stationary phase-specific sigma factor s in the decrease in cell viability caused by

spermidine.Biochem. Boiophys. Res. Commun. 264:643-347.

3. Apirakaramwong, A., Fukuchi, J., Kashiwagi, K., Kakinuma, Y., Ito, E., Ishihama, A., and

65

Igarashi, K. (1998). Enhancement of cell death due to decrease in Mg2+ uptake by

OmpC (cation-selective porin) deficiency in ribosome modulation factor-deficient mutant.

Biochem. Boiophys. Res. Commun. 251:482-487.

Asst.Prof.Dr.Manat Pongchaidecha

Research

1. Daley-Yates, P.T., Cal, J.C., Cockshott, A., Pongchaidecha, M., and Gilchrist, K. (1992).

Plasma protein binding of APD: role of calcium and tranferrin. Chem.-Biol. Interactions.

81:79-89.

2. Daley-Yates, P.T., Dodwell, D.J., Pongchaidecha, M., Coleman, R.E., and Howell, A.

(1991). The clearance and bioavailability of paridronate in patients with breast cancer and

bone metastases. Calcif. Tissue Int. 49:433-435.

Asst.Prof.Dr.Nalinee Poolsup

Research

1. Li Wan Po, A., Herxheimer, A., Poolsup, N., Aziz, Z. (2001). How do Cochrane reviewers

address adverse effects of drug therapy?MG Newsletter. (June):20-21.

2. Poolsup, N., Li Wan Po, A., Knight, T.L. (2000). Pharmacogenetics and

psychopharmacotherapy. J. Clin. Pharm. Ther. 25:197-220.

3. Poolsup, N., Li Wan Po, A., and de Oliveira, I.R. (2000). Systematic overviews of lithium

treatment in acute mania. J. Clin. Pharm. Ther. 25:139-156.

4. Poolsup, N., Li Won Po, A., Oye bade, F. (1999). Measuring mania: a critical appraisal of

rating scales. J. Clin. Pharm. Ther. 24:433-443.

Asst.Prof.Dr.Watcharee Leurmarnkul

Research

1. Leurmarnkul, W. (2000). Health-related quality of life questionnire development. Thai. J.

Pharm. Sci. 24(2):71-85.

2. Leurmarnku., W., and Meetam, P. (2000). Development of a quality of life questionnaire:

SF-36 (Thai Version). Thai. J. Pharm. Sci. 24(2):92-111.

Ms.Karunrat Tewthanom

Research

H. Tewthanom K., Thongnopnua P., Pitragool R., Tewthanom K., Lukanajuntachod P,

Koikul J, Jainark P. Relationship between serum and saliva theophylline level in patient

66

with respiratory tract disease: A case study at Samutsakorn hospital in Jidavijak B,

Chulavatnatol S, Montakantikul P, Tunyasansuk K. Facing Changes in Pharmacotherapy

and Pharmacy profession. 1 st ed, The asscociation of hospital pharmacist (Thailand),

Bangkok, Thailand, 2002.

I. Tewthanom K. Therapeutic Drug Monitoring of antiretroviral: differences viewpoint.

Silpakorn University Journal 2001:Vol 21;107-HIH.

J. Tewthanom K. Saliva Therapeutic Drug Monitoring; new strategy for drug monitoring.

Silpakorn University Journal 2000:Vol 19-IS;HJS-KI.

K. Sompubut J., Sangpoum P., Tongplub R., Tewthanom K., Pongchaidacha M. Chaipak

V., Prukpakpoom A, Pitragool W. Monitoring of patient's serum theophylline level: case

study at Samutsakorn hospital in Chulavatnatol S,Suthisrisang C. Evidence-based

medicine for pharmacists. 1 st ed, The asscociation of hospital pharmacist (Thailand),

Bangkok, Thailand, 2000.

L. Sompubut J., Sangpoum P., Tongplub R., Tewthanom K., Pongchaidacha M. Chaipak

V., Prukpakpoom A, Pitragool W. Monitoring of patient's serum theophylline level: case

study at Samutsakorn hospital. Thailand regional and general hospital society

ISSS;U(HS):HS-HK.

Asst.Prof.Dr.Onooma Poobrasert

Research

1. Chantasitiporn, J., Chumchit, C., Tanamatayarat, P., Wongtieng, W., Yaipakdee, P., and

Poobrasert, O. (2000). Biological activity of plant extracts from Thai traditional

medical text for cancer therapy. J. Multidisciplinary Res. 13:24-28.

2. Poobrasert, O. (1999). Physostigmine: A revisit. Silpakorn Univ. J. 18:116-128.

3. Poobrasert, O., Constant, H.L., Beecher, C.W.W., Farnsworth, N.R., Kinghorn, A.D.,

Pezzuto, J.M., Cordell, G.A., Santisuk, T., and Reutrakul, V. (1998). Zanthones from the

twigs of Mammae siamensis. Phytochemistry 47:1661-1663.

4. Poobrasert, O., Cordell, G.A., and Bobzin, S.C. (1997). Blue degredation products of

rubreserine. J. Nat. Prod. 60:578-580.

5. Shao, Y., Ho, C.-T., Chin, C.-K., Poobrasert, O., Yang, S.-W., and Cordell, G.A. (1997).

Asterlingulatosides C and D, cytotoxic triterpenoid saponins from Aster Lingulatus. J. Nat.

Prod. 60:743-746.

67

Assoc.Prof. Lawan Sriphong

Research

1. Grobuschek, N., Sriphong, L., Schmid, M. G., Lorand, T., Aboul-Enein, H. Y. and Gubitz,

G. (2002) Chiral separation of bioactive cyclic Mannich ketones by HPLC and CE using

cellulose derivatives and cyclodextrins as chiral selectors, J. Biochem. Biophys. Methods

53:25-36.

2. Sriphong, L. (2002) Topical drugs : Computer-assisted instruction in pharmaceutical

chemistry course, Proceeding in the 19th Asian Congress of Pharmaceutical Sciences of

the Federal of Asian Pharmaceutical Associations, 5-8 October 2002.

3. Sriphong, L., Limsirichaikul, S., Wetwitayaklung, P., and Sotanaphun, U. (2000). A novel

cytotoxic alkaloid from the flowers of Senna spectabillis D.C. The symposium of young

scientists of the European Phytochemistry Society: Future Trends in Phytochemistry,

Rolduc, The Netherlands 7-11 May 2000.

4. Sriphong, L., Shik, K.Y., Toida, T., and Imanari, T. (2000). Isolation and characterization

of acharan sulfate from the giant snail Achatina fulica. The JSPS-NRCT fifth joint seminar:

Natural Medicine, Chulalongkorn University, Bangkok, Thailand, 15-17 November 2000.

5. Sriphong, L., Burana-Osott, J., Toida, T. and Imanari, T. (1999). Establishment of

disaccharide analysis from fully N-acetyled heparin and heparin sulfate. The Japaneses

Pharmaceutical Sciences Meeting, Tokushima, Japan, 27-31 March.

Asst.Prof.Dr.Panadda Yaipakdee

Research

1. Yaipakdee, P. and Robertson, L.W. (2001). Enzymatic halogenation of flavanones and

flavones. Phytochemistry 57(3):341-347.

2. Chantasitiporn, J., Chumchit, C., Tanamatayarat, P., Wongtieng, W., Yaipakdee, P., and

Poobrasert, O. (2000/2001). Biological activity of plant extracts from Thai traditional text

for cancer therapy. Journal of Multidisciplinary Research 13:24-28.

3. Yaipakdee, P. (2000). Application of combinatorial synthesis in drug discovery process.

Thai J. Pharm. Sci. 24(3-4):121-142.

4. Yaipakdee, P. (2000). Drug discovery from microorganisms. Silpakorn University Journal

19-20(2):70-94.

5. Yaipakdee, P. (1998). Cyclic peptides: a new target for antifungal therapy. Silpakorn

University Journal 18(1):156-166.

68

Asst.Prof.Dr.Chutima Limmatvapirat

Research

1. Jaruchoktaweechai, C., Suwanborirux, K., Tanasupawat, S., Kittakoop, P., and

Menasresta, P. (2000). New macrolactins from a marine Bacillus sp. Sc026. J. Nat. Prod.

63:984-986.

Asst.Prof.Jankana Buranaosot

Research

1. Burana-osot, J and Buchbauer, J., Determination of volatile compounds from Hoya

carnosa, (L.f.) R.Br. (Asclepiadaceae) flowers. Thai J. Pharm. Sci. 26 (1-2): 39-44 (2002).

2. Burana-osot, J. and Yanpaisan, W. (2002) Simple and simultaneous determination of

individual catechins and xanthines in green tea. Proceeding of the 19th Congress of

FAPA, Seminar on Asian Congress of Pharmaceutical Science and Practice, 5-8 October,

Seoul, Korea.

Dr.Amornrut Chaidedgumjorn

Research

1. Chaidedgumjorn A, Suzuki A, Toyoda H, Toida T, Imanari T, Linhardt RJ. Conductivity

detection for molecular mass estimation of per-O-sulfonated glycosaminoglycans

separated by high-performance size-exclusion chromatography. J Chromatogr A. 2002;

2. Chaidedgumjorn A, Toyoda H, Woo ER, Lee KB, Kim YS, Toida T, Imanari T. Effect of

(1 3)-and (1 4)-linkages of fully sulfated polysaccharides on their anticoagulant

activity Carbohydr Res. 2002;337 (01):925-33.

3. Sudo M, Sato K, Chaidedgumjorn A, Toyoda H, Toida T, Imanari T. 1H nuclear magnetic

resonance spectroscopic analysis for determination of glucuronic and iduronic acids in

dermatan sulfate, heparin, and heparan sulfate. Anal Biochem. 2001;297(1):42-51.

4. Toida T, Suzuki A, Nakajima K, Chaidedgumjorn A, Imanari T. Effect of 6-O-sulfonate

hexosamine residue on anticoagulant activity of fully O-sulfonated

5. Chaidedgumjorn A, Todida T, Imanari T,Woo ER,Park H, Linhardt RJ, Woo SJ and Kim

YS. A new sulfated beta-galactan from clams with anti-HIV activity. Carbohydr Res,

1999;337(10):925-33.

69

Asst.Prof.Chatchai Chinpaisal

Research

1. Wei, L-N., Hu, X., and Chinpaisal, C. (2000). Constitutive activation of retinoic acid

receptor beta2 promoter by orphan nuclear receptor TR2. J. Biol. Chem. 27(16):11907-

11914.

2. Lee C.H., Chinpaisal, C. and Wei, L.N. (1998). A novel nuclear receptor

heterodimerization pathway mediated by orphan receptors TR2 and TR4. J. Biol. Chem.

273(39):25209-25215.

3. Chinpaisal C., Lee, C.H., and Wei, L.N. (1998). Mechanisms of the mouse orphan nuclear

receptor TR2-11-medicated gene suppression. J. Biol. Chem. 273(29):18077-18085.

4. Yu, Z., Lee, C.H., Chinpaisal, C., and Wei, L.N. (1998). A constitutive nuclear localization

signal from the second zinc-finger of orphan nuclear receptor TR2. J. Endocrinol.

159(1):53-60.

5. Lee, C.H., Chinpaisal, C., and Wei, L.N. (1998). Cloning and characterization of mouse

RIP140, a corepressor for nuclear orphan receptor TR2. Mol. Cell. Biol. 18(11):6745-

6755.

Asst.Prof.Dr.Wandee Yanpaisan

Research

1. Yanpaisan, W., King, N.J.C., and Doran, P.M. (1999). Flow cytometry of plant cells with

applications in large-scale bioprocessing. Biotechnology Advances 17:3-27.

2. Yanpaisan, W., King, N.J.C., and Doran, P.M. (1998). Analysis of cell cycle activity and

population dynamics in heterogeneous plant cell suspension using flow cytometry. Journal

of Biotechnology and Bioengineering 58:515-528.

3. Yanpaisan W. (1989). The effect of phytohormones and some additives on tissue culture

establishment and in vitro production of alkaloids from Arcangelsa flava Merr. Journal of

the National Research Council of Thailand 21(1).

4. Yanpaisan, W., King, N.J.C., and Doran, P.M. (1997). Flow cytometry analysis of cell

cycle activity and population dynamics in suspended plant cell culture. American Institute

of Chemiscal Engineers 1997 Annual Meeting, Los Angeles, CA, 16-21 November.

70

Dr.Penpun Wetwitayaklung

Research

1. Wissenschaftliche Tagung der Osterreichischen Pharmazeutischen Gesellschaft, 30

September –2 October 1999, In Innsbruck.” P.Wetwitayaklung, G.Ecker and

W.Fleischhacker

2. XVIth International Symposium on Medicinal Chemistry, 18-22 September 2000, In

Bologna, Italy. “Synthesis and MDR-Modulating Activity of Enantiopure 1-

Benzopyrano[3,4-b][1,4]oxazines” P.Wetwitayaklung, P.Chiba and G.Ecker

3. 222nd American Chemical Society National Meeting, 26-30 August 2001, In Chicago.

Illinois. “A Hologram QSAR analysis of Benzopyrane-type Modulators of Multidrug

Resistance” P.Wetwitayaklung, D.Kaiser, P.Chiba and G.Ecker

4. 16th Scientific Congress of the Austrian Pharmaceutical Society to gether with 4th Central

European Symposium on Pharmaceutical Technology, 23-25 September 2001, In Vienna,

Austria. “Synthesis and MDR Modulating Activity of Enantiopure Benzopyrano[3,4-

b][1,4]oxazines” P.Wetwitayaklung, S.Kopp, P.Chiba and G.Ecker

Asst.Prof.Dr.Uthai Sotanaphun

Research

1. Ngamkham, J., Ondee, S., Sotanaphun, U., Sittisombut, C. and Picha, P. (2001). Cytotoxicity of

leaf extracts of Plu, Piper betle on cultured mammalian neoplastic cells. 16th Asian-Pacific

cancer congress 2001. Manila, Philippine, 18-21 Nov.

2. Sotanaphun, U., Lipipun, V. and Bavovada, R. (2001). Phenolic-(9→8)-D:A-friedo-24-

noroleananes : A new class of antiviral agents. Pharma Indochina II, Hanoi, Vietnam, 20-23

Oct.

3. Bavovada, R., Chavalittumrong, P., Pingsuthiwong, C., Sotanaphun, U., Sukhakul, T.,

Thongphasuk, P. and Thanakijcharoenpath, W. Chemical and ethnobotanical in vestigation of

Thai Strychnos species. NRCT-JSPS core university system on pharmaceutical sciences. The

fifth joint seminar : Natural medicines. Bangkok, Thailand, 15-17 Nov.

4. Sripong, L., Sotanaphun, U., Vajvittayaklung, P. and Limsirichaikul, S. (2000). The alkaloids

from the flower of Cassia spectabilis D.C. and their cytotoxic activity. The symposium of young

scientists of the European Phytochemistry Society : Future trends in phytochemistry. Rolduc,

Natherlands, 7-11 May.

5. Sotanaphun, U., Suttisri, R., Lipipun, V. and Bavovada, R. (2000). A new 3,4-seco-ursane

triterpenoid from Glyptopetalum sclerocarpum. Chem. Pharm. Bull. 48(9), 1347-1349.

71

Asst.Prof.Wanchai Sutananta

Research

1. Sutananta, W., Craig, D.Q.M., and Newton, J.M. (1996). The use of low frequency

dielectric spectroscopy as a means of characterising the effects of moisture uptake by

pharmaceutical glyceride bases. Int. J. Pharm. 132:1-8.

2. Sutananta, W., Craig, D.Q.M., and Newton, J.M. (1995). The use of low frequency

dielectric spectroscopy as a novel means of investigating the structure of pharmaceutical

glyceride bases. Int. J. Pharm. 125:123-132.

3. Sutananta, W., Craig, D.Q.M., and Newton, J.M. (1995). An evaluation of the mechanism

of drug release from glyceride bases. J. Pharm. Pharmacol. 47:182-187.

4. Sutananta, W., Craig, D.Q.M., and Newton, J.M. (1995). An Investigating into the effect of

preparation conditions and storage on the rate of drug release from pharmaceutical

glyceride bases. J. Pharm. Pharmacol. 47:355-359.

5. Sutananta, W., Craig, D.Q.M., and Newton, J.M. (1994). The investigating into the effect

of preparation conditions on the structure of pharmaceutical glycerides using differential

scanning calorimetry and polarized light microscopy. Int. J. Pharm. 110:75-91.

Asst.Prof.Dr.Suwannee Panomsuk

Research

1. Koizumi, T., Panomsuk, S.P., Hatanaka, T., and Katayama, K. (1996). Kinetics of swelling

of compressed cellulose matrices : A mathematical model. Pharm. Res. 13:329-333.

2. Panomsuk, S.P., Hatanaka, T., Aiba, T., Katayama K., and Koizumi. (1996). A study of

the hydrophilic cellulose matrix : Effect of drugs on swelling properties. Chem. Pharm.

Bull. 44:1039-1042.

3. Koizumi, T. and Panomsuk, S.P. (1995). Release of medicaments from the spherical

matrices containing drug in suspension : Theoretical aspects. Int. J. Pharm. 166:45-49.

Asst.Prof.Dr.Sontaya Limmatvapirat

Research

1. Luangtana-Anan, M. Limmatvapirat, S. Development of readily soluble and less irritate

indomethacine tablet, Silparkorn University Journal 2536;13:24-32.

2. Limmatvapirat, S. Inclusion compound formation between deoxycholic acid and guest by

grinding and sealed heating, Proceeding of the 116th Annual Meeting of Association of

Pharmacy, Japan, 1996, 17.

72

3. Limmatvapirat, S. Yonemochi, E. Oguchi, T. Yamamoto K. Complex formation between

deoxycholic acid and menadione by grinding and sealed heating method. Chem Pharm

Bull 1997;45:1358-1362.

4. Limmatvapirat, S. Inclusion compound formation between deoxycholic acid and salicylic

acid by grinding method. Yakuzaigaku 1997;57:176-177.

5. Limmatvapirat, S. Yamaguchi, K. Yonemochi, E. Oguchi, T. A 1:1 deoxycholic-salicylic

acid complex. Acta Cryst C 1997;C53:803-805.

Asst.Prof.Dr.Pornsak Sriamornsak

Research

1. Sriamornsak P, Nunthanid J, Wanchana S, and Luangtana-anan A. Composite film-

coated tablets intended for colon-specific delivery of 5-aminosalicylic acid using

desterified pectin. Pharmaceutical Development and Technology 2003; in press.

2. Nunthanid J, Wanchana S, Sriamornsak P, Limmatavapirat S, Luangtana-anan and

Puttipipatkhachorn S. Effect of heat on characteristics of chitosan film coated on

theophylline tablets. Drug Development and Industrial Pharmacy 2002; 28: 919-930.

3. Sriamornsak P. Effect of calcium concentration, hardening agent and drying condition on

release characteristics of oral proteins from calcium pectinate gel beads. European

Journal of Pharmaceutical Sciences 1999; 8(3): 221-227.

4. Sriamornsak P and Nunthanid J. Calcium pectinate gel beads for controlled release drug

delivery: II. Effect of formulation and processing variables on drug release. Journal of

Microencapsulation 1999; 16(3): 303-313.

5. Sungthongjeen S, Pitaksuteepong T, Somsiri A and Sriamornsak P. Studies on pectins as

potential controlled-release matrix tablets. Drug Development and Industrial Pharmacy

1999; 25: 1271-1276.

Asst.Prof.Dr.Somluk Kongmuang

Research

1. Kongmuang, S. (1991). Mechanism of increasing dissolution by solid dispersion

technique. Thai. J. Pharm. Sci. 16

73

Assoc.Prof.Dr.Jurairat Nanthanid

Research

1. Puttipipatkhachorn, S., Nunthanid, J., Yamamoto, K., and Peck, G.E. (2001). Drug

physical state and drug-polymer interaction on drug release from chitosan matrix films. J.

Control. Rel. 75(1-2):143-153.

2. Nunthanid, J., Puttipipatkhachorn, S., Yamamoto, K., and Peck, G.E. (2001). Physical

properties and molecular behaviors of chitosan films. Drug Dev. Ind. Pharm. 27(2):143-

157.

3. Sriamornsak, P. and Nunthanid, J. (1999). Calcium pectinate gel beads for controlled

release drug delivery: II. Effect of formulation and processing variables on drug release.

J. Microencap. 16(3):303-313.

4. Sriamornsak, P. and Nunthanid, J. (1998). Calcium pectinate gel beads for controlled

release drug delivery: I. Preparation and in-vitro release studies. Int. J. Pharm. 160:207-

212.

5. Nunthanid, J., Chalongsuk, R., and Leelasa-ngaluk, V. (1993). Study of knowledge,

attitude, and practice of people on Village-Drug-Co-Operatives in Nakornpathom province.

Silpakorn Unviersity Journal 13:35-47.

Asst.Prof.Dr.Gaysorn Chansiri

Research

1. Chansiri, G., Lyon, R.T., Patel, M.V., and Hem, S.L. (1999). Effect of Surface Charge on

the Stability of Oil/Water Emulsions during Steam Sterilization. J. Pharm. Sci. 88(4):454-

458.

2. Chansiri, G. (1998). Lipid Emulsions : A Potential Carrier for Drug Targeting to the

Reticuloendothelial System. Silpakorn University Journal 18(1):192-199.

3. Chansiri, G., Chansiri, K., Tan-ariya, P., Nokdhes, C., and Sarataphan, N. (1998). Efficacy

of Medicinal Plants as Anti-parasitic Drugs Against Theileria Sp. In In-Vitro Culture of

Infected Bovine Erythrocytes. Silpakorn University Journal 18(1):39-50.

4. Gruenhagen, S.E., Schulze, D.G., Chansiri, G., Hem, K.J., White, J.L., and Hem, S.L.

(1997) Effect of Sorbitol on the Phosphate Adsorptive Capacity of Ferrihydrite

Suspension. Pharm. Dev. Technol. 2(1):81-86.

74

Dr.Nattawat Natpoolwat

Research

1. Palanuphap S, Mitrevej A, Sinchaipanid N, Natpoolwat C. Study on deformation of direct

compression fillers using computerized technology. Presented at The Academic Annual

Meeting, The Pharmaceutical Association of Thailand under Royal Patronage, Petchaburi,

April 1995.

2. Natpoolwat C, Mitrevej A, Junyaprasert V, Sinchaipanid N, Naratikornrit N. Study of

aqueous colloidal ethylcellulose on drug release from propanolol hydrochloride pellets.

Presented at The Academic Annual Meeting, The Pharmaceutical Association of Thailand

under Royal Patronage, Petchaburi, April 1995.

3. Mitrevej A, Sinchaipanid N, Natpoolwat N, Sermsuppasuk P, Supattanawong P.

Preparation of sustained release phenylpropanolamine hydrochloride - wax matrices in

hard gelatin capsules. Asian J Pharm 1996; 16: D-17.

4. Sinchaipanid N, Mitrevej A, Natpoolwat N. Enteric film coating with methacrylic acid –

methacrylate copolymer aqueous dispersion (Eudragit L30D-55). J Ind Pharm 1997; 2(3):

70-5.

5. Mitrevej A, Sinchaipanid N, Natpoolwat N, Naratikornrit N. Design and fabrication of

multi – unit controlled release phenylpropanolamine hydrochloride capsules and tablets.

Drug Dev Ind Pharm 1998; 24(8): 793-6.

Asst.Prof.Dr.Thanasat Ngawhirunpat

Research

1. Tanasait Ngawhirunpat, Hiroshi Yoshikawa , Tomomi Hatanaka, Tamotsu Koizumi, Isao

Adachi. Age-related changes in skin permeability of hydrophilic and lipophilic compounds

in rats. Pharmazie 56 , 3, 231-234 (2001).

2. Tanasait Ngawhirunpat, Tomomi Hatanaka, Junichi Kawakami, Isao Adachi. Age

difference in simultaneous permeation and metabolism of ethyl nicotinate in rat skin. Biol.

Pharm. Bull.24 (4) 414-417 (2001).

3. Tanasait Ngawhirunpat, Hiroshi Yoshikawa , Tomomi Hatanaka, Kazunori Katayama,

Junichi Kawakami, Isao Adachi. Change in electrophysiological properties of rat skin with

age. Change in electrophysiological properties of rat skin with age. Biol. Pharm. Bull.25

(9) 1192-1196 (2002).

4. Tanasait Ngawhirunpat, Praneet Opanasopit, Korakot Chaturon, Jamaree

Leewansangthong, Suwannee Panomsuk. In vitro permeation of ketoprofen gel: Effect of

Carbopol 940 and Pluronic F-127. Silpakon J. 18 (1), 79-86 (1998)

75

Asst.Prof.Dr.Praneet Opanasopit

Research

1. Praneet Opanasopit, Keiko Shiraishi, Makiya Nishikawa, Fumiyoshi Yamashita, Yoshinobu

Takakura, and Mitsuru Hashida In vivo recognition of mannosylated proteins by hepatic

mannose receptors and mannan-binding protein. Am. J. of Physiol. Gastrointest liver

Physiol, 280, G879-G889 (2001)

2. Praneet Opanasopit, Yuriko Higuchi, Shigeru Kawakami, Fumiyoshi Yamashita, Makiya

Nishikawa, and Mitsuru Hashida Involvement of serum mannan binding proteins and

mannose receptors in uptake of mannosylated liposomes by macrophages. Biochim.

Biophys. Acta. 1511(1):134-145. (2001)

3. Praneet Opanasopit, Makiya Nishikawa, Fumiyoshi Yamashita, Yoshinobu Takakura, and

Mitsuru Hashida Pharmacokinetic analysis of Lectin-dependent biodistribution of fucosylated

bovine serum albumin: A possible carrier for kupffer cells. J. Drug Targeting, Vol 9: 341-

351 (2001)

4. Praneet Opanasopit, megumi Sakai, Makiya Nishikawa, Shigeru Kawakami, Fumiyoshi

Yamashita, and Mitsuru Hashida Inhibition of experimental liver metastasis by lectin-

mediated targeting of immunomodulators to liver nonparenchymal cells using

mannosylated liposomes. J. Controlled Release, 80 (1-3),283-294 (2002).

5. Praneet Opanasopit, Kenji Hyoudou, Makiya Nishikawa, Fumiyoshi Yamashita, and

Mitsuru Hashida Serum mannan binding protein inhibits mannosylated liposome-mediated

transfection to macrophages. Biochim. Biophys. Acta. 1570, 203-209 (2002).

Asst.Prof.Dr.Thawatchai Phaechamud

Research

1. Rittidej, G.C., Phaechamud, T., and Koizumi, T. (2001). Moist heat treatment on

physicochemical change of chitosan salt films. Int. J. Pharm. (In press)

2. Koizumi, T., Rittidej, G.C., and Phaechamud, T. (2001). Mechanistic modeling of drug

release from chitosan coated tablets. J. Control. Rel. 70:277-841.

3. Phaechamud, T., Koizumi, T., and Ritthidej, G.C. (2000). Chitosan citrate as film former:

compatibility with water-soluble anionic dyes and drug dissolution from coated tablet. Int.

J. Pharm. 198:97-111.

4. Ritthidej, G.C., Phaechamud, T., and Koizumi, T. (2000). Additives in moist-heat-treated

chitosan acetate films: a method to extend the release of propranolol hydrochloride-

coated tablets. STP. Pharma. Sci. 10(1):112-119.

5. Phaechamud, T. (1997). Colonic drug delivery: study and strategy. Thai J. Pharm. Sci.

21:7-20.

76

Dr.Panida Asavapichayont

Research

1. Asavapichayont, P. and Foldvari, M. (2000). Improved method for high performance

liquid chromatograghic analysis of tetracaine and its metabolite in human skin

homogenate. Manuscript in preparation

2. Asavapichayont, P., and Foldvari, M. (2000). Kinetic study of tetracaine hydrolysis in

human skin homogenate. Manuscript in preparation.

3. Asavapichayont, P., Naik, R., and Foldvari, M. (2000). Development of an in vitro viable

skin model for the simultaneous assessment of delivery and cutaneous metabolism of

ester drugs. Manuscript in preparation; to be submitted to the Journal of Investigative

Dermatology.

4. Asavapichayont, P. and Foldvari, M. (1998). Dermal delivery of ester type drugs: the fate

of tetracaine in human skin homogenate. Pharm. Sci. 1(1):S-373.

5. Asavapichayont, P., Hu, J. and Foldvari, M. (1997). Development of an HPLC method for

simultaneous analysis of tetracaine and its metabolite in dosage forms and biological

fluids, with comparison to capillary electrophoresis method. Pharm. Res. 14(11):S-565.

Assoc.Prof.Dr.Manee Laungtana-anan

Research

1. Luangtana-Anan, M. Limmatavapirat S, Sripong L. and Fell J.T. (1996). Physical and

chemical stability of film coated ranitidine tablets. Archives of Pharm. Res.

2. Luangtana-Anan, M. and Limmatavapirat, S. (1993). Development of readily soluble and

less Irritated indomethacin tablet. Journal of Silpakorn University 13:24-32.

3. Luangtana-Anan, M., Catellani P.L., Colombo, P., Dinarvand, R. and Fell, J.T. (1992). The

role of bond weakening by liquids in the disintegration of tablets. The European Jounal of

Pharmaceutics and Biopharmaceutics 38(5):169-171.

4. Luangtana-Anan, M. and Fell, J.T. (1990). Bonding Mechanisms in Tableting. International

Journal of Pharmaceutics 60:197-202.

5. Luangtana-Anan, M. and Fell, J.T. (1988). Surface energies of Pharmaceutical solids

before and after compaction. International Journal of Pharmaceutics 41:237-240.

77

Asst.Prof.Prasert Akkaramongkolporn

Research

1. Akkaramongkolporn P., Etsuo Y. and Terada K. (2000). Molecular state of

chlorpheniramine in resinates. Chem. Pharm. Bull. 48(2):231-234.

2. Akkaramongkolporn P. (1997). Behavior of drug loading onto cation-exchange resin by

batch multiple equilibria method. Thai J. Pharm. Sci. 21(2):99-106.

3. Akkaramongkolporn P. (1997). Kinetic of Drug Loading onto Cation-exchange Resin and

Effect of Concurrent Counter-ions. Thai J. Pharm. Sci. 21(1):33-42.

4. Akkaramongkolporn P. and Prakongpan S. (1996). Production of sustained release

dosage form using ion-exchange resin. J. Indust. Pharm. 1(1):1-9.

Dr.Surawut Watana

Research

1. Dihydroxyvitamin D-3 may stabilize osteocalcin m RNA via the predicted stem-

loop structure in the 5’-UTR. FASEB Journal,14(8):1482.(2000)

Dr.Wisit Tangkeangsirisin

Research

1. Tangkeangsirisin, W., Thientanawat, A., Brodie, A., and Serrero, G. (2000)

Adipocyte Differentiation-related Protein Reduces Aromatase Activity. School of

Pharmacy University of Maryland, Baltimore, MD, May 2000.

2. Tangkeangsirisin, W. and Serrero, G. (2001) Role of PC-cell Derived Growth

Factor in Estrogen Responsiveness and Drug Resistance in Human Breast

Cancers. 23rd Annual Graduate Research Conference, University of Maryland,

Baltimore, MD, April 2001. Cancer Biology B Session.

3. Tangkeangsirisin, W., Huifeng, D., Xufeng C. and Serrero, G. (2002) Role of

PC-cell derived Growth Factor in the Estrogen Responsiveness and Anti-

estrogen Resistance in Human Breast Cancer, 24th Annual Graduate Research

Conference, University of Maryland, Baltimore County, MD, April 2002. Cancer

Biology Session.

4. Tangkeangsirisin, W., Huifeng, D., Xufeng C. and Serrero, G. (2002) Role of

PC-Cell Derived Growth Factor in the Alteration of Estrogen Responsiveness

78

and in the Acquisition of Anti-estrogen Resistance in Human Breast Cancer,

American Association of Cancer Research 93rd Annual Meeting, San Francisco,

CA.

5. Tangkeangsirisin, W. and Serrero, G. (2003) Adipose Differentiation-related

Protein (ADRP) Induces Differentiation of Human Breast Cancer MCF-7 Cells,

American Association of Cancer Research 94th Annual Meeting, Washington,

DC.

6. Tangkeangsirisin, W. and Serrero, G. (2003, in press) Resveratrol in the

Chemoprevention and Chemotherapy of Breast Cancer, CRC Press.

7. Tangkeangsirisin, W., Hayashi, J. and Serrero, G. (2004) PC Cell-Derived

Growth Factor Mediates Tamoxifen Resistance and Promotes Tumor Growth of

Human Breast Cancer Cells. Cancer Res, 64, 1737-43.

8. Tangkeangsirisin, W. and Serrero, G. (2004, in press) PC Cell-Derived Growth

Factor (PCDGF/GP88, progranulin) Stimulates Migration, Invasiveness and

VEGF expression in Breast Cancer Cells. Carcinogenesis.

9. Tangkeangsirisin, W. and Serrero, G. (2003, on preparing) ADRP induces cell

differentiation in breast cancer.

Dr Suang Rungpragayphan

Research

1. Suang Rungpragayphan, Yasuaki Kawarasaki, Takao Imaeda, Katsunori Kohda,

Hideo Nakano, and Tsuneo Yamane. (2002) High-throughput, cloning-

independent protein library construction by combining single-molecule DNA

amplification with in vitro expression. Journal of Molecular Biology. 318, 395-

405.

2. Suang Rungpragayphan, Hideo Nakano, and Tsuneo Yamane. (2003) PCR-

linked in vitro expression: a novel system for high-throughput construction and

screening of protein libraries. FEBS Letters. 540, 147-150.

3. Suang Rungpragayphan, Megumi Haba, Hideo Nakano, and Tsuneo Yamane.

Rapid screening for affinity-improved scFvs by means of single-molecule-PCR-

linked in vitro expression. ( Journal of Molecular Catalysis B: Enzymatic, in

press)

72

รายละเอยดงบประมาณ

หลกสตรเภสชศาสตรบณทต (หลกสตรนานาชาต)

คณะเภสชศาสตร มหาวทยาลยศลปากร

1. รายรบ ตอนกศกษา 1 รน (60 คน/รน ระยะเวลารวม 10 ภาค การศกษาปกต) 1.1 รายรบสวนกลางมหาวทยาลย

- คาบารงการเปนนกศกษามหาวทยาลยศลปากร 600,000.- บาท - คาบารงและคาธรรมเนยมอ,น ๆ 798,000.- บาท

1.2 รายรบสวนของคณะเภสชศาสตร - คาหนวยกต (500,000 บาท x 60 คน ) 30,000,000.- บาท - คาธรรมเนยมพเศษ (250,000 บาท x 60 คน) 15,000,000.- บาท

รวมรายรบสาหรบการบรหารจดการและดาเนนการหลกสตร (เฉพาะคณะเภสชฯ) 45,000,000.- บาท

2. รายจาย ตอนกศกษา 1 รน (60 คน /รน ระยะเวลารวม 10 ภาคการศกษาปกต) 2.1 เงนจดสรรจากรายรบเฉพาะคาหนวยกตเขามหาวทยาลยรอยละ 6 1,800,000.- บาท 2.2 รายจายจากการบรหารจดการและดาเนนการหลกสตร(เฉพาะคณะเภสชฯ) 29,029,000.- บาท

รวมรายจาย (2.1 + 2.2 ) 30,829,000.- บาท 3. รายรบหลงหกรายจายทBงหมด 14,171,000.- บาท 4. รายจายเปนงบลงทนทางการศกษาเพ,อการพฒนาเชงรก 5,000,000.- บาท

รายละเอยดรายจายในการบรหารจดการหลกสตร

รายละเอยดของรายจายองตามเกณฑระเบยบมหาวทยาลยศลปากรวาดวยคาใชจายในการบรหารและจดการหลกสตรของมหาวทยาลยศลปากรในลกษณะโครงการพเศษ พ.ศ. 2538 และฉบบท, 2 พ.ศ. 2539 โดยประมาณการคาใชจายดงนB 1. คาตอบแทน

- คาตอบแทนอาจารยพเศษ/อาจารยของรายวชาตามหลกสตร 4,816,500.- บาท - คาตอบแทนผประสานงานรายวชา 362,500.- บาท - คาตอบแทนอาจารยในงานบรหารธรการหลกสตร 12,000,000.- บาท - คาตอบแทนเจาหนาท,ในการปฏบตงานตามโครงการ 2,400,000.- บาท - คาตอบแทนลกจางในการปฏบตงานตามโครงการ 900,000.- บาท

73

2. คาตอบแทนในลกษณะเบBยประชมตลอด 5 ป การศกษา

- สาหรบกรรมการดาเนนงานโครงการไมเกนครB งละ/คนละ 500 บาท 1,200,000.- บาท 3. คาตอบแทนผตรวจบญชอนญาต 48,000.- บาท 4. คาใชจายในการเดนทางเพ,อปฏบตหนาท,ตามหลกสตร - คาใชจายในการเดนทางของกรรมการไมเกนวงเงนปละ 250,000 บาท 1,250,000.- บาท - คาใชจายในการเดนทางของอาจารย/เจาหนาท,ไมเกนปละ 200,000 บาท 1,000,000.- บาท5. คาสาธารณปโภค 400,000.- บาท6. คาวสด/อปกรณวทยาศาสตร/สารเคม 4,452,000.- บาท7. คาใชจายอ,น ๆ 200,000.- บาท รวมคาใชจายในการบรหารจดการหลกสตร 29,029,000.- บาท

จานวนนกศกษา ณ จดคมทน = = 41.1 ~ 41 คน

ประมาณการคาใชจายตอนกศกษา 1 คน

ประมาณการคาใชจายตอนกศกษา 1 รน = 30,829,000.- บาท

ประมาณการคาใชจายตอนกศกษา 1 คน ตลอดหลกสตร = 30,829,000.- บาท = 513,817.- บาท หรอ 102,765.- บาท/ป

750,000.- บาท/คน 30,829,000.- บาท

60 คน

74

Budget

The administrative cost of the program will be supported by tuition fees and spicial fees of approximately 773,300 Baht per student for entire program. The break even cost will be couered at number of 41 students in each enrollment.

Estimated revenue and expenses

For the total of 60 students in each enrollment ,the nevenue and expenses are as the following: (1) revenue (750,000 x 60 ) 45,000,000.- Baht

1.1 tuition fee (30,000,000 Baht) 1.2 special fee (15,000,000 Baht)

(2) expenses 30,829,000.- Baht 2.1 administrative cost (1,800,000 Baht) 2.2 operational cost (29,029,000 Baht) (3) gross revenue 14,171,000.- Baht (4) investment & development cost 5,000,000.- Baht Estimated cost per each graduate 513,817.- Baht

Or 102,765.- Baht/year

International Pharmacy.pdf - Free Web Hosting Area

Documents

Transcript of International Pharmacy.pdf - Free Web Hosting Area